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CHAPTER 1
INTRODUCTION
Yersinia

species use a type III secretion system in

order to subvert host cell defenses.

Type III secretion

systems are a unique way for gram negative bacteria to
inject protein toxins directly into a target cell.

These

protein toxins must be transported through the gram
negative double membrane, as well as past the cell wall
of the target cell.

This requires the utilization of a

long bacterial needle of 50nm or more (Blocker et
2 001, Kimbrough et

al.,

al.,

2 000, Kubori et al., 2 000).

Once

inside the target cell, these protein toxins carry out a
wide range of functions.

Yersinia
Alexandre Yersin and Shibasaburo Kitasato
independently discovered Yersinia
1894, and Kitasato, 1894).
named Pasteurella
Yersinia

pestis

pestis.,

pestis

in 1894 (Yersin,

Originally the bacterium was
but was later changed to

in 1970.

Yersin was able to isolate the

bacterium during the Manchurian epidemic that was
sweeping across Asia.

He was the first to show that the

bacterium was present in both human and rat populations
and postulated a mode of transmission for the disease.

1

2
Yersinia

spp. are gram negative, rod shaped,

facultative anaerobes which infect a wide range of
mammals (Pollitzer and Meyer, 1961, Gage, 1999).
pathogenicity of Yersinia

can be attributed to the use of

a type III secretion system.
Yersinia

The

Of the eleven known
Yersinia

species there are only three pathogenic

spp. These three species show significant sequence
homology, however differ widely in their pathogenicity.
The reason for this can be found by looking in their
genomes.
Population studies have shown that Y. pestis
from Y. pseudotuberculosis
(Achtman et al.,

1999).

evolved

only 1,500-20,000 years ago
Evidence for this comes from the

fact that there is little variation between Y.

pestis

strains, indicating that it must have diverged recently
(Achtman et al.,
Y. pestis

1999) .

Furthermore, sequencing of the

genome showed it contains many base changes

that are not found in Y. pseudotuberculosis

which is

thought to be the parental strain (Achtman et al.,

1999).

Some of these changes have been postulated to be an
important cause of the virulence of Y.
Furthermore, the Y. pestis

pestis.

genome is full of potential

sites of lateral gene transfer, with some of these sites

3
showing homology to insect pathogens (Wren, 2003).

The

loss of these insect pathogen genes seems to be a crucial
element in the virulence of Y. pestis
pseudotuberculosis

(Wren, 2003).

as compared to Y.

The Y. pestis

genome

also shows an unusual amount of insertion sequences, or
IS elements, indicating sites for homologous
recombination (Wren, 2003).

One significant

characteristic of these IS elements is their ability to
move around the genome.

They are flanked on either side

by inverted repeats and carry their own transposases to
insert themselves into the genome.

Finally, Y.

pestis

has acquired two plasmids, pPla and pMTl (Wren, 2003).
The first plasmid, pPla, received its name because it
encodes for the plasminogen activator Pla (Brubaker,
1991).

Plasmid MT1 encodes for the F capsule, a

structural gene as well as the murine toxin Ymt (Wren,
2003).

All of these findings indicate key differences in

the genomes of Yersinia

pestis

and

Yersinia

pseudotuberculosis.

Also, they show evidence that Y.

pseudotuberculosis

is the parental strain. Overall, Y.

pestis

acquired its virulence through a combination of

mutation, loss of some genes, plasmid acquisition and
movement of IS elements.

4

Yersinia

pestis--History

Yersinia
plagues.

pestis

is responsible for several worldwide

The first definitive report of plague occurred

in 532 AD in Egypt (Perry and Fetherston, 1997) .

This

plague swept across North Africa, Europe, and Asia
killing 50-60% of the population (Perry and Fetherston,
1997).

The second pandemic, known as the Black Death,

reached epidemic proportions in the 14 th century when it
swept through Europe killing at least two-thirds of the
population (Perry and Fetherston, 1997). The third
pandemic occurred in China in 1855, and spread throughout
the world.

In China and India alone, 12 million people

succumbed to the plague during this pandemic (Perry and
Fetherston, 1997).

This third pandemic is responsible

for the cases of plague that we still see today.
Today, however, the plague is generally regarded to
be under control since currently only 10-20 cases of
plague are reported in the United States per year and of
those cases only 14% are fatal (CDC, 2005).

The drop in

mortality can be accredited to advances in modern
medicine and sanitation (Inglesby et al. , 2000) .
Alarmingly, drug resistant forms of the bacteria have
been found (Galimand et al.,

1997, Anisimov, et al,

which allows the potential use of Yersinia

pestis

2006)

as a

5
The use of Yersinia

biological weapon.

as a biological

weapon turned into reality during WWII.

It is

hypothesized that during this war the Japanese army
dropped plague infected fleas over China.

More recently,

a more efficient means to disseminate plague has been
developed.

At least two countries, the United States and

the former Soviet Union, have been successful in
aerosolizing the plague (Inglesby et al.,

2000) .

This

gives potential terrorists an easy way to disseminate the
bacteria over a wide population.
property of Y. pestis

Another attractive

is that it is naturally occuring,

making disguising an attack easier. In order to determine
whether a plague outbreak is from a naturally occurring
source within the rodent population or a terrorist
attack, Inglesby notes that we would need to observe the
number of rodent deaths preceding the outbreak (2 000).
Yersinia

pestis--

Infection

The three pathogenic Yersinia

species are

responsible for numerous diseases including
gastroenteritis {Y.
pseudotuberculosis),
and plague (Y. pestis).

enterocolitica

and

Y.

avian plague {Y.
Yersinia

different modes of transmission.

pseudotuberculosis)

spp. also have
Y. pestis

is primarily

an enzootic disease, meaning it is prevelant in animals

6
enterocolitica

from a certain geographical region, while
and pseudotuberculosis

are enteropathogenic.

The most common vector for Y. pestis

is the flea,

which acquires the bacteria by biting an infected animal.
The bacteria are able to propagate within the flea
midgut, blocking the flea from further meals (Bacot and
Martin, 1914, Perry and Fetherston, 1997, Hinnebusch et
al. , 1998) .

Bacot and Martin also proposed that this

proventricular blockage was responsible for the
dissemination of plague (1914).

As the blocked flea

tries to feed on its next meal, a human for example, the
proventricular blockage causes the bacteria to be
regurgitated.

Once a human is bitten these bacteria then

migrate through the circulatory system, where they spread
to the lungs or the lymphatic system.

The human immune

system tries to phagocytize the bacteria, however
Yersinia

are not destroyed due to the action of the

effector proteins.

Infection of the lymph nodes causes

swelling and these enlarged lymph nodes are called
buboes.

The formation of these buboes is where bubonic

plague received its name.
move into the blood stream.

Next, the bacteria are able to
If the bacteria colonize the

lungs, pneumonic plague develops.

The bacteria can exit
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the body via the eyes, nose and mouth and can be
transmitted from person to person.
Enteropathogenic Yersinia--

Infection

The mode of infection for enteropathic Yersinia
quite different.

Enteropathic Yersinia

is

must first be

ingested from contaminated food or water, or by fecal to
oral transmission.

Once ingested, Yersinia

bacteria make

their way through the intestine to the terminal ileum.
Upon arrival at the terminal ileum, the bacteria attach
and invade the lumen.

Next, the bacteria moves into the

M cells, which are specialized cells that cover Peyers
patches (Grutzkau, et al.,

1990, Hanski, et al.,

1989,

Une, 1977) . M cells have the unique ability to deliver
antigens from the lumen of the intestine to other cells
on the basolateral side.

The invasion is thought to be

due to the action of a protein called invasin.
is an outer membrane protein of Yersinia

Invasin

that shows an

affinity for binding (31 integrin receptors.

The only

cell known to express (31 receptors in the intestine are M
cells (Clark et al.,

1998).

mutations in invasion

(inv),

Bacteria that carry
a gene necessary for cell

penetration of the bacterium (Isberg et al.,

1987), show

a decrease in the ability to colonize Peyers patches.
This indicates that inv

is essential for the execution of

8
this activity (Pepe et al.,

1993, Schulte et al.,

1996).

Once invasion of Peyers patches has begun, YadA, becomes
expressed and is required for efficient translocation of
effector proteins (Cornelis et al.,

1998, Eitel and

Dersch, 2002) .
Type III Secretion
In Yersinia,

Type III secretion is responsible for

translocating effector proteins.

Secretion may be a

misnomer, since the effector proteins are not actually
secreted into the extracellular space, but rather
translocated into the target cell cytoplasm.

However,

Type III secretion is utilized by many nonpathogenic
organisms.

The discovery that symbiotic and commensal

bacteria possess a type III secretion system came as a
surprise and occurred only after the sequencing of
bacterial genomes became widespread.
bacterium is Rhizobium

fredii,

Type III secretion in Rhizobium
(Marie et al.,

One such symbiotic

although the function of
is not fully understood

2001) . Not only is type III secretion

present in plant pathogens but can also be found in
animal symbionts. The bacterium Sodalis

glossinidius

infects grain weevils and possesses a Type III secretion
system (Dale et al. , 2001) . Again, the function of the

9
Type III secretion system in

S.

glossinidius

has not been

completely elucidated.
These findings indicate that Type III secretion may
not just be a means for gram negative bacteria to inject
protein toxins into a host cell, since non-pathogenic
bacteria possess them as well.

This insinuates that

there is another reason.for the evolution of Type III
secretion.

One theory is that the Type III secretion

system was a means of communication between bacterial and
eukaryotic cells before its injection of toxins function
evolved.
In Type III secretion systems, injection of the
effector proteins occurs through a needle-like structure
named the injectisome, which shows remarkable structural
similarities to the flagellum.

The flagellum uses a type

III secretion-like method to pump the flagellins, the
proteins that make up the filament of the flagella,
through the apparatus (Cornells 2002, Journet et
2003).

al.,

Comparative genetic analysis of the flagellum and

type III secretion apparatus has identified 10 genes with
sequence homology

(Piano et al,

2001).

Along with the

sequence homology, visualization of the flagellum and
needle structure also indicate widespread
between the two structures.

similarities

The most homology can be
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seen in the basal body, the MS ring and C ring of the
fl age H u m

(Macnab, 1999) . The similarities between these

two systems have given rise to the discussion of which
arose first; flagellum or secretion.

The most likely

hypothesis is that flagella evolved first since many
different prokaryotes possess them.

Furthermore, type

III secretion would only have been useful after the
evolution of eukaryotes (Macnab 19 99).

An argument can

be made for the reverse hypothesis stating that flagella
evolved from TTSS.

Since flagellar signal sequences have

been located on secreted proteins of TTSS, which suggests
that TTSS had to evolve first (Lee and Galan 2004) .
Translocation Apparatus
In Type III secretion, effector proteins cross the
bacterial inner and outer membrane as well as the
eukaryotic cell membrane and arrive in the target cell
cytoplasm.

In the case of Yersinia,

usually a macrophage.

the target cell is

In order for this to occur the

bacterial cell must first form the translocon.

This

apparatus is responsible for forming the pore that is
needed to transfer effectors.

Components of the pore

include YopB, D and LcrV.
In order to translocate the effectors, YopB is
inserted into the membrane with the help of YopD to form
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a pore.

Deletion of yopB and/or yopD causes a loss of

translocation to occur (Rosqvist et al.,

1994).

Complementation of only yopB or yopD on a plasmid is
unable to restore function by itself, indicating both
protein products must be present (Hartland et al. , 1996).
Moreover, upon immunoprecipitation YopB and YopD are
shown to coprecipitate (Neyt et al.,

1999).

YopB and

YopD are stabilized before secretion by their chaperone
LcrH (Edqvist, et al.,

2007).

LcrH is responsible for

regulating the amount of YopB and YopD secreted (Edqvist,
et al.,

2007).

It is important for this pore to remain

closed when the bacterium is not in contact with a target
cell to prevent premature leaking of the effectors into
the extracellular milieu. To regulate this, YopN and TyeA
act as a plug to prevent leaking or premature
translocation of the effectors.

LcrV initially was

connected with keeping the pore closed. However, deletion
of lcrV does not affect Yop secretion, but it does
prevent secretion of YopB and D (Sarker et al.,

1998).

It was shown that LcrV actually binds to YopD using a
GST-pull down assay (Sarker et al.,

1998), which

indicates that LcrV and YopD interact.

GST stands for

glutathione S-transferase and is commonly used as a tag
to precipitate proteins in complex.
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Now that a completed and functional translocon has
been assembled, there are many other proteins needed
before translocation can actually occur.
secretion in Yersinia
that the yscN

is ATP driven.

Type III

It has been found

gene product has some homology to the p-

catalytic subunit of the F0Fi ATPase.

Woestyn et

al.,

(1994) have shown that yscN is 29% identical to the (3subunit and 25% identical to the a subunit of FQFi ATPase.
This has led researchers to hypothesize that YscN may
actually act as an ATPase (Woestyn et al. , 1994), and
drive translocation of the Yops.

YscN has also been

grouped into a class of proteins known as AAA+ proteins
(ATPases Associated with various cellular Activities).
These proteins have numerous functions throughout the
cell, one of which being protein unfolding, (reviewed in
Sauer et al.,

2004).

It is postulated that YscN may also

possess protein unfolding ability since it belongs to
this class of proteins.

Unfolding is predicted to be an

important function in Type III secretion.

Based on the

size of the needle, it is unlikely that a folded effector
protein can pass through without some change in
structure.

Presumably then, there must be a protein to

unfold the effector prior to translocation. Recently a
regulatory protein for YscN has been discovered, YscL

13
(Blaylock et al. , 2006).

In the presence of YscL, YscN

has a notable decrease in ATPase activity (Blaylock et
al.,

2006).

YscN may also be bound to the type III

secretion apparatus through association of YscL with YscQ
(Blaylock et al.,

2006).

This association would ensure

that YscN is always available and does not need to be
recruited to the apparatus before translocation can begin
(Blaylock et al.,

2006).

Another essential protein for translocation is YscP
which has been shown to act as a ruler for needle length.
As the needle grows, YscP stretches and once it has
elongated completely, the needle stops growing.

At this

point, YscP is translocated into the target cell (Thomas
et al.,

2004, Payne and Straley, 1999).

insertion mutations of yscP
length.

Deletion and

result in a needle of varying

This implies a direct correlation between the

length of the yscP
al. , 2003).

protein and needle length (Journet et

Another, interesting function of YscP is

the ability to switch from needle elongation for growth
to secretion of effector proteins.

This purpose is

fulfilled through the C-terminal end of the protein which
contains a type III secretion substrate specificity
switch (T3S4) domain (Agrain et al.,

2005, Journet et

al. , 2003) . The switch is located between residues 385-

14
500.

This region has been shown to control both needle

length and Yop secretion and subsequently must contain
the switch (Journet et al., 2003) .

Journet et

al.,

(2003) were able to remove yscP and replace it with
homologues from other species.
ascP from Aeromonas
aeruginosa,
Yersinia

salmonicida,

They specifically tested
pscP from

and fliK from Salmonella
pestis.

Pseudomonas

typhimurium

and

Only ascP and pscP were able to restore

function, while FliK from either species was not.

This

indicates that the switch is specific to type III
secretion and not the flagellar system (Agrain et

al.,

2005).
Chaperones
Many of the Yop effectors are associated with
chaperones. Currently there are three known types of type
III secretion chaperones.

Class I chaperones are

responsible for binding to the effector proteins, class
II chaperones are involved in formation in formation of
the translocation pore, and class III chaperones are
involved in assembling the injectisome apparatus..
chaperones are not secreted into the target cell.

These
Early

work suggested that chaperones may be required to keep
the Yop protein unfolded for translocation (Stebbins and
Galan, 2001) or inactive while in the bacterium, however
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recent work on SycO the YopO chaperone, and SycE, the
YopE chaperone refute this idea. The presence of SycE
does not affect the GAP activity of YopE implying the GAP
region is folded correctly and active(Birtalan et al. ,
2002).

Removing the SycO binding domain has no effect on

the kinase or actin binding activities of YopO suggesting
that these domains are indeed folded correctly (Letzelter
et al. , 2006) . Another early hypothesis was that
chaperones could be used to keep Yop effectors soluble.
In the case of YopO, this may be one of the functions,
since removal of the chaperone binding domain causes YopO
to become insoluble (Letzelter et al.,

2006) .

An

interesting discovery is that in the case of YopO, the
chaperone binding domain overlaps the membrane
localization domain, and in YopH it overlaps the
translocation signal (Letzelter et al.,

2006).

Covering

the membrane localization domain and translocation signal
while still in the bacterium would prevent premature
translocation of the effectors.

16

Yersinia

Outer Proteins

YopH
YopH is a powerful protein tyrosine phosphatase
(PTP), and is essential for virulence of Yersinia
(Guan and Dixon, 1990, Bliska et al.,

spp.

1991, Persson et

al. , 1995) . The amino terminal end of the protein
contains a chaperone binding domain (amino acids 20-70)
which also functions to bind substrates for the catalytic
domain (Black et al.,

1998). The catalytic domain spans

amino acids 190-468 (Black et al.,

2000) (Table 1 ) .

To assess the ability of YopH to dephosphorylate
host cell proteins, host proteins from Y.
pseudotuberculosis
labeled with
PAGE.

mouse monocyte-macrophages were
32

P.

The extracts were resolved using SDS-

This analysis showed that YopH was able to

dephosphorylate a wide range of proteins including
proteins of 200, 120, and 60 kDa in size (Bliska et
1991).

al.,

Two specific proteins shown to co-precipitate

with YopH are Cas and FAK. Cas (Crk associated substrate)
is a docking protein, and is involved in normal cell
function through integrin mediated signal transduction
and the actin cytoskeleton (Hamid et al.,

1999, Donaldson

17
et al. , 2000) . FAK is a tyrosine kinase that is activated
by autophosphorylation at the SH2 domain.

After

phosphorylation FAK can interact with downstream
signaling proteins. It is thought that YopH disrupts the
p1 integrin focal adhesion complex by dephosphorylating
pl30cas (Persson et al. , 1997).

By disrupting this

complex, phagocytosis of the bacterium is impaired.
In vivo,

the activity of YopH results in

dephosphorylation of almost all substrate proteins,
making it one of the most potent PTPases identified. This
dephosphorylation blocks lymphocyte activation by
inactivating the antigen receptor-signaling complex (Yao
et al.,

1999) and also inhibits the ability of T cells to

produce cytokines and pump calcium which in turn blocks
phagocytosis (Yao et al. , 1999) .
Not only can YopH inhibit the ability of T cells to
pump calcium, YopH is also able to disrupt Ca2+ signaling
in neutrophils (Andersson et al.,

1999).

One function of

meutrophils is to activate signaling cascades within the
body which elevate the level of Ca2+.

The ability of YopH

to disrupt calcium signaling, was elucidated by using
mutant Y. pseudotuberculosis

strains.

These strains

express either a catalytically deficient or WT copy of
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yopH but express no other Yops (Andersson et al.,

1999).

The catalytically deficient YopH strain was not able to
block calcium signaling like the WT YopH strain.
Therefore showing that the PTPase activity of YopH is an
essential function to block calcium signaling (Andersson
et al. , 1999).
YopT
YopT is a cysteine protease which affects the
cytoskeleton by cleaving the Rho family of small GTPases
from the membrane and in turn disrupts actin filaments
(Table 1 ) . The Rho family of small GTPases is a subgroup
of the Ras superfamily of GTP binding proteins, which are
involved in cytoskeletal rearrangements and phagocytosis
(Dukuzumuremyi et

al.,

2000) among other important

cellular functions. All Rho GTPases are posttranslationally modified.

This modification occurs at

the C-terminal CaaX box (a= any aliphatic residue, and X=
any residue).

First, the cysteine is prenylated, then

the aaX domain is removed and lastly the cysteine residue
is carboxymethylated

(Fueller et al.,

2006).

These

modifications allow Rho GTPases to be targeted to the
membrane (Zhang and Casey, 19 96) .
YopT achieves cytoskeletal disruption by liberating
RhoA from the membrane which occurs by cleaving the C-

19
terminal prenyl group attached to the cysteine residue
(Shao et al. , 2002 and 2003) . /To assess if YopT has a
preference for active or inactive RhoA, HEK293 cells coexpressing a constitutively active radioactively labeled
Rho (RhoAL63) and a nucleotide free Rho again
radioactively labeled (RhoAN19).

YopT was able to cleave

the radioactive label from both the active RhoA and
inactive RhoA indicating no preference for one over the
other.

Once liberated, Rho loses its function within the

cell which causes a loss of stress fibers within the
cell, and subsequently cell rounding. YopT is also
targeted to the membrane upon infection, which is in
complete agreement with the fact that RhoA is anchored to
the membrane (Fueller et al.,
In vivo

2006).

studies have shown that YopT is not•

essential for lethality (Iriarte and Cornells, 1998,
Viboud et al.,

2006).

In a mouse infection model, yopT

deficient strains showed no attenuation in virulence
(Viboud et al.,

2006).

This indicates that YopT is not

an essential virulence determinant when other effectors
are p r e s e n t .

YopE
YopE is a GTPase activating protein that contains a
secretion and translocation domain.

YopE contains two
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translocation signals, both located at the N-terminus of
the protein.

The first translocation signal encompasses

the first 15 residues is sufficient for reporter
translocation (Michiels and Cornells, 1991).
Nevertheless, the second sequence which includes the
first 50 amino acids and the chaperone binding site is
needed to translocate hybrid proteins (Cheng et

al.,

1997) (Table 1 ) .
Expressing YopE as a GST fusion and RhoA, Racl, Ras
and Cdc42, as radioactively labeled GST fusion proteins,
Black and Bliska (2000) showed that YopE could increase
the GTPase activity of RhoA, Racl and Cdc42, but not of
Ras.

In addition to increasing the GTPase activity of

RhoA, Racl and Cdc42, YopE may also play a role in
increasing the levels of IL-1(3.

A AyopPE strain caused

an increase in the amount of IL-lp produced (Schotte et
al.,

2004) compared to just the AyopP and wild type

strains. Increasing GTPase and the amount of IL-1(3 are
only two of the potential functions of YopE within the
cell.

An additional fuction of YopE maybe to abolish GAP

activity.
et al.,

Mutation of yopE abolishes GAP activity (Aili

2002), however this mutated form of YopE still

conveys cytotoxicity (Aili et al.,

2003) suggesting

another role for YopE within the cell.
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In vitro

experiments by Black and Bliska (Black and

Bliska, 2000) using mice infected with bacteria
expressing yopE,
virulence.

showed that YopE is essential for

Expression of only YopE in this model caused

virulence at normal levels.
YopM
YopM is a highly acidic protein that contains
leucine rich repeats (LRR).

These LRR regions vary from

20-22 residues (Benabdillah et al,

2004) (Table 1 ) .

Unlike many of the other Yops, YopM is not homogenous
between strains.

The difference in length between YopM

proteins is likely due to the variation of the LRR region
of the proteins and may have occurred accidentally
through duplication (Cornells et al. , 2002).
Interestingly, this is the only Yop that travels to the
nucleus, via vesicular mediated transport (Skrzypek et
al.,

2003) . YopM is able to travel to the nucleus by a

nuclear localization signal (NLS) located at the Cterminus of the protein (Benabdillah et al,

2004) .

YopM

also contains a secretion signal located in the Nterminal 40 amino acids of the protein (Boland et

al.,

1996).
Once in the nucleus, YopM has been shown to inhibit
IL-15 and its receptor (Kerschen et al.,

2004) which is
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responsible for proper NK cell function (Prlic et al. ,
2004).

Through immunoprecipitation, YopM has been shown

to form a complex with two-proteins, PRK2 and RSK1
(McDonald et al. , 2003).

It is important to note that

these two kinases do not normally interact in cells that
do not contain YopM (McDonald et al.,

2003) .

These

results indicate that YopM may act as a protein scaffold.
Protein scaffolds can recruit proteins, and may be able
to regulate activity of the bound proteins and their
specificity (Levchenko et al.,
experiment by Heusipp et al.

2006).

A similar

shows that YopM interacts

with AAT (al-antitrypsin), but has no effect on AAT's
serine protease activity (Heusipp et al.,

2006) .

There

is no known biological function for YopM binding AAT.
In vivo

studies on YopM using flow cytometry

identified NK cells as a primary target of YopM (Kerschen
et al.,

2004).

This experiment determined that YopM

affects the immune system by decreasing the level of NK
cells (Kerschen et al.,

2004).

YopP
YopP is responsible for TNF-a suppression during
Yersinia

infection.

Based on homology, it is also

thought that YopP may act as a cysteine protease,

23
specifically belonging to the ubiquitin-like proteases
(Orth et al.,

2000) (Table 1 ) .

Recent research shows that YopP may directly bind
members of the MAPK kinase family, which then functions
as an upstream activator of MAPK (Orth et al.,

1999).

Several pathways including osmolarity and mating are
activated by MAPK, both of which have been shown to be
inhibited by YopP in yeast (Orth et al.,

1999).

A mouse infection model shows that a yopP mutant

strain of Yersinia

pseudotuberculosis

resulted in a

decrease in virulence (Trulzsch et al.,

2004).

Further

studies by this group also show that YopP specifically
acted to decrease the amount of CD8 T cells (Trulzsch et
al.,

2005).

The reason for this decrease in CD8 T cells

is unknown.
YopO
YopO is a serine-threonine kinase that is cytotoxic
to mammalian and yeast cells (Galyov et al.,
et al., 2 000, Dukuzumuremyi et
al. , 2002) .

al.,

1993, Juris

2000, Nejedlik et

It is 729 amino acids in length with a

calculated size of 81.7 kDa making it the largest Yop.
YopO contains a number of domains.

These domains include

a chaperone binding domain (CBD) (amino acid 20-70),
membrane localization domain (MLD)(aa 20-90) (Letzelter
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et al.,

2006), actin binding site (aa 89-440) (Trasak et

al. , 2006), kinase domain (aa 160-400), Rho/Rac binding
domain (aa 436-710) and another actin binding domain (aa
709-729) (Dukuzumuremyi et al.,

2000, Trasak et

al.,

2006) (Table 1 ) .
Rho/Rac binding

CBD/MLD

Kinase
Actin Binding

Actin Binding

Figure 1. Diagram of YopO. The YopO protein is 729
amino acids in length, with multiple domains. CBD=
chaperone binding domain MLD= membrane localization
domain.
Initially, YopO is produced as an"inactive kinase,
until the protein associates with actin at which time
YopO autophosphorylates(Juris et al. , 2000).

To identify

which protein(s) were responsible for YopO activation,
total cell protein was fractionated and then assayed for
YopO kinase activation.

Truncating the C-terminal end of

YopO inhibits the binding of actin and subsequently the
activation of the protein (Juris et al.,

2000).

Recent

research has identified a second actin binding region
located in the N-terminal end of the protein.

Mutation
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of either of these binding sites show a decrease in
autophosphorylation by the kinase domain, indicating both
the N-terminal and C-terminal binding sites are needed
for the full activity of YopO (Trasak et al.,

2006) .

There are two types of actin present in the cell, G-actin
and F-actin, in order to determine which type was able to
activate YopO kinase activity, autophosphorylation was
assayed in the presence of G-actin and F-actin (Trasak et
al. , 2006) . Autophosphorylation was only detected in
samples containing G-actin (Trasak et al.,

2006) .

In addition to the kinase domain, YopO also contains
a Rho/Rac binding domain, which directly interacts with
the small GTPases, RhoA and Racl.

Rho and Racl are

members of the Ras family of GTP binding proteins and
have a role in cytoskeletal rearrangements
et al. , 2000) .

(Dukuzumuremyi

Co-purification of YopO occurred with

mammalian RhoA, Racl, but not with Cdc42. This indicates
that YopO interacts with RhoA and Racl, but not Cdc42.
Also, no phosphorylation by YopO occurred while bound to
either mammalian RhoA or Racl (Dukuzumuremyi et

al.,

2 000). YopO showed no preference for binding RhoA or Racl
when bound to GDP or GTP either (Dukuzumuremyi et
2000).

al.,

Looking at the co-crystal structure Prehna et

al.

(2006) was able to show that YopO is able to bind GTPases
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and stop nucleotide exchange, thus acting as a guanidine
nucleotide dissociation inhibitor (GDI) and deactivating
the GTPase.
Recently otubain-1 and gaq have been discovered as
potential targets of YopO.

Otubain-1 is phosphorylated

by YopO when actin is present.

Otubain-1 is also known
al.,

to interact with the actin cytoskeleton (Juris et
2006).
Gaq.

Navarro(2007) have shown that YopO phosphorylates
To assess the ability of YopO to phosphorylate Gaq,

the authors transfected HEK293A cells with YopO, or a
kinase mutation that abolishes kinase activity.

The

transfected cells were then incubated with
[32P]orthosphosphate.

Phosphorylated proteins

incorporated the radioactive label, were separated by SDS
gel and observed using autoradiography.

The results

showed that YopO was able to phosphorylate Gaq, but the
inactive kinase was not.

This information indicates that

the kinase domain located in the N-terminus of the
protein is essential for phosphorylation of the protein.
The exact reason that YopO phosphorylates Gaq is unclear
at this time.

However., Gaq is a heterotrimeric G-protein

that regulates several cellular activities.

One of these

cellular activities is the activation of pathways
controlled by RhoA (Navarro et al. , 2007) .

Previous work
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has shown that YopO interacts directly with RhoA.

It

looks as though YopO is able to exert an effect on a wide
range of proteins in this pathway in order to disrupt the
actin cytoskeleton.
There have been mixed results in

vivo

as to whether

or not YopO is an essential virulence determinant.

One

study which showed that YopO was not essential, used a
strain that also had a mutation in the YadA gene which
could account for the WT colonization of the spleen
(Galyov et al.,

1994).

There are at least two other

studies that have shown that YopO is an essential
virulence determinant
al.,

, 2003, Triilzsch et

2004) .

Table 1.

Yop

(Logsdon et al.

Size, protein length and domains of each Yop.

kDa

Amino
acids

YopH
YopT
YopE
YopM
YopP

41.6
32 .5

468
322
220
379
288

YopO

81. 7

729

51
35.5

23

Domains
Protein tyrosine phosphatase
Cysteine protease
GTPase activating protein

LRR
Cysteine protease, MAPK' binding
domain
Serine/Threonine Kinase, Rho/Rac
binding domain, Actin binding
domain, MLD
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Summary
Yersinia

spp. cause a wide variety of diseases, from

the benign gastroenteritis to the potentially fatal black
plague.

Although the last reported epidemic of plague

occurred in the 1800s, and can be routinely treated with
antibiotics, there have been antibiotic resistant forms
of Yersinia

pestis,

the causative agent of the plague,

reported (Galimand et al.,

1997, Anisimov, et al,

To cause disease Yersinia

2006).

spp. use a type III

secretion system, to deliver protein toxin across the
bacterial inner and outer membrane and into the target
eukaryotic cell.

Translocation occurs via an injectisome

that is assembled when the bacteria comes in direct
contact with the target cell.

To date six effector

proteins have been identified, Yops H, 0, M, E, T and P.
These Yops may have distinct functions with in the cell,
but work in concert to overcome the target cell defenses
and prevent phagocytosis.
The focus of this study is YopO.

YopO is a complex

protein, with many functional domains, the exact
physiological functions of which are unknown.
of this study is to use Saccharyomyces

cerevisiae

The goal
as a

model system to study and identify the target(s) of YopO.
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CHAPTER 2
ACTIN DISTRIBUTION IS DISRUPTED UPON EXPRESSION OF
YOPO/YPKA IN YEAST
Summary
These results have been previously published in
Nejedlik et al. , 2 0 04.

The manuscript can be found in

its entirety in appendix A page number 82.
The hypothesis we started with was that YopO would
be lethal in yeast when expressed from an inducible
promoter.

We also expect localization to occur at the

cell periphery and disrupt actin as previously
demonstrated (Hakansson et al. , 1996) .

In order to

further assess the role of each domain within the YopO
protein, several mutants were constructed and assayed for
lethality, localization and actin disruption.
I have shown with this work that YopO is indeed
lethal in yeast validating our hypothesis.

Furthermore,

the kinase domain was not essential for this lethality,
however the actin and Rho binding domains are.

These

results indicate that the C-terminal portion of YopO is
essential for lethality in yeast and interacts presumably
with actin and/or Rho, to cause this lethality.
the kinase domain is not essential for lethality,

Since
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phosphorylation of these proteins should also not be
essential.
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CHAPTER 3
CHARACTERIZATION OF S406 MUTATION
Introduction
Our laboratory has begun a mutagenesis of YopO to
further elucidate which domains are essential for
lethality.

Determining which domains are essential for

lethality, will allow researchers to focus on particular
regions of the protein in order to develop strategies to
combat disease.

As previously reported (Galyov et al. ,

1994, Dukuzumuremyi et al.,

2000, Juris et al.,

2000,

Letzelter et al. , 2006, Trasak et al. , 2007)- YopO
contains several domains, indicating it might be a multifunctional protein.

To date the following domains have

been identified and include, an actin binding domain, two
Rho binding domains, a membrane localization domain, a
chaperone binding domain and a serine/threonine kinase
domain.
As previously described in Nejedlik et al.,

2004, we

have constructed several yopO mutations to analyze these
domains and determine which ones are needed for YopO
lethality in yeast.

These mutations include D267A, which

changes the aspartic acid at position 267 to an alanine,

32
and the second mutation is 1543 which produces a stop
codon at position 543.
An additional mutation to those previously studied
was constructed, S406, which produces only amino acids
406-720.

This region encompasses only the actin and Rho

binding domains, but does not produce the N-terminus of
the protein.

Therefore, it does not produce the membrane

binding domain, chaperone binding domain or the
serine/threonine kinase domain. This mutation will allow
us to analyze if the actin and Rho binding domains are
sufficient to cause lethality, or if additional domains
are needed.

It will also allow us to analyze if the

actin and Rho binding domains alone are able to cause WT
YopO localization, and actin disruption as previously
reported.
Our assumption was that a YopO protein containing
only the actin and Rho binding domains would be
sufficient for YopO to cause lethality.

We also assumed

that actin would be affected similarly in cells
containing the S406 mutation as cells expressing YopO,
since the actin and Rho binding domains are intact and a
functional kinase domain is not required for this effect
(Juris et al,

2000, Nejedlik et al. , 2004).

Cells

expressing YopO exhibit a loss of actin cables and a
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decrease in the amount of actin cortical patches.

We

also hypothesized that localization of YopO to the cell
periphery would not be effected in this mutant either.
The reason for this is because Rho proteins are normally
anchored in the membrane, therefore if our mutant is
interacting with Rho, the two proteins would presumably
co-localize. To analyze these hypotheses we performed
similar studies as previously described looking at
lethality, actin distribution, and localization in
strains containing the S406 mutation.
With this work I have shown that the actin and Rho
binding domains are sufficient to cause lethality,
however they alone do not cause YopO to localize to the
cell periphery as we expected.

This is in agreement with

the finding that YopO contains a membrane localization
domain which is deleted in this mutant (Letzelter et al. ,
2006).

Also, actin localization in this mutant showed

wild type actin distribution with actin cables and
patches present at all time points observed.

This

finding is surprising since S406 contains the actin
binding domain and a functional kinase domain is not
needed for actin disruption (Juris et al. , 2000, Nejedlik
et al.,

2004) .

This finding could be due to the fact
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that YopO is not localized to the cell periphery, where
Rho proteins would be found.
Materials and Methods
Media
All yeast media (YPD, SD-leu, SD-ura, SD-ura-leu,
Sgal-ura, Sgal-leu, Sgal-ura-leu) were prepared as
previously described (Guthrie and Fink, 1991).

LB media

(LB + ampicillin) was prepared as previously described
(Sambrook and Russell 2001).
Creation of S406 plasmid
S406 was PCR amplified from pLN5, which was created
as described in chapter 2 (Table 3) using primers
GGGGACAAGTTTGTACAAAAAAGCAGGCTCAAtgagcgacggaact
GGGGACCACTTTGTACAAGAAAGCTGGGTCTGCcatccattcccgctc
The resulting amplified PCR product was combined with
pJG52 0 (Table 3 ) , using the GATEWAY™ BP reaction
(Invitrogen).

This reaction resulted in the creation of

pJG521, which contains only amino acids 406-729.

Using

this plasmid we utilized the GATEWAY™ LR reaction
(Invitrogen) to create plasmid pLN12 by combining pJG52 0
and pJG484.

The resulting plasmid has a LEU2 auxotrophic

marker as well as YopO from amino acids 406-720. The
plasmid was sequenced to ensure there were no additional
mutations present.
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Transformation
Transformations of yeast strains were performed as
previously described (Gietz and Schiestl, 1991) .
Assaying YopO Lethality
Yeast strain JGY4 (Table 2) was transformed as
previously described with S406 (pLN12), YopO (pLN5) or an
empty vector control plasmid (pJG484).

Resulting

transformants were restreaked and grown overnight in S
raffinose-ura (Control and pLN5) or S raffinose-leu
(pLN12) media.

Cultures were serially diluted onto YPD,

SD-ura (Control and pLN5), SD-leu (pLN12), Sgal-ura
(Control and pLN5) and Sgal-leu (pLN12) media.
Titer assays were performed by first growing strains
overnight in S raffinose-ura (Control and pLN5) or S
raffinose-leu media (pLN12) and diluted to 30 Klett the
next day.

Cells were allowed to grow in appropriate

media to log phase, around 50 Klett, at which time
galactose was added to a final concentration of 2% to
induce expression of YopO.

Samples of induced and

uninduced cultures were taken at one hour intervals.
Induced and uninduced yeast samples were plated onto
appropriate SD media, thus removing the inducer.

Plates

were allowed to grow at room temperature for four days at
which time colonies were counted.
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Actin Localization
Strains were grown as described for the titer assay
above, except cells at each time point were fixed in
formaldehyde at a final concentration of 3.7% for two
hours at room temperature, or overnight at 4°C.

Cells

were resuspended in PBS-BSA (phosphate buffered salinebovine serum albumin) at a concentration of 0.04% BSA.
Rhodamine-Phallodin (Molecular Probes) was added for
visualization of actin at a final concentration of 66
units/ml.

Samples were incubated in the dark at room

temperature for 30 minutes, after which time cells were
washed three times with 1ml of PBS-BSA and resuspended in
100 ul PBS-BSA.

Samples were viewed under a Texas red

filter set on a Leica DM5500B microscope equipped with a
Q-Imaging Retiga Exi 1394 Fast camera.
YopO Immunofluorescence
Strains were grown as previously described in the
titer assay.

Cells were fixed as described above.

Cells

were then incubated in 1.2 M Sorbitol, 25 mM (3mercaptoethanol, 100 mM KP04 and zymolyase for one hour
at 30°C with rocking.

This allows for degradation of the

cell wall which in turn allows the antibodies to enter
the cell.

Cells were then washed with PBS containing

0.04% BSA and centrifuged at 3-4,000 rpm to concentrate
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the cells.

Polylysine (0.1%) was applied to each well of

the polyteflon immunoflourescence slide (Polysciences,
Inc) and allowed to dry at room temperature.

Wells were

washed vigorously with dH20 and allowed to dry, and
subsequently washed three times with PBS-BSA.

Each well

received 20 ul of digested cells and the cells were
incubated at room temperature for five minutes.

Wells

were aspirated and washed three times with PBS-BSA.
Mouse monoclonal anti-V5 antibody (Invitrogen) was
diluted 1:800 in PBS-BSA and applied to each well of the
slide.

The slide was then incubated in the dark at room

temperature for two hours. Cells were washed three times
with PBS-BSA and the secondary antibody anti-mouse CY2,
which was diluted 1:100 in PBS-BSA, was applied to each
well and incubated in the dark for 2 hours at room
temperature.

To visualize microtubules rat YOL 1/34 was

used at a dilution of 1:400 in PBS-BSA and incubated at
room temperature for two hours in the dark.

Cells were

washed three times with PBS-BSA and the secondary
antibody, goat anti-rat Texas Red was applied at a
concentration of 1:100 in PBS-BSA.

incubated in the dark for two hours.

The slide was

After washing three

times with PBS-BSA cells were stained with DAPI at a
final concentration of 1 ug/ml (Sigma-Aldrich) to
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visualize DNA for 3 minutes at room temperature. Wells
were again washed three times with PBS-BSA before
mounting.

Cells were visualized using a Leica DM5500B

microscope with a Q-Imaging Retiga Exi 1394 Fast camera.
Western Blot
Performed as described in Nejedlik et al.

(2004) .

Table 2. Yeast strain used in characterization of yopO
mutation S406.
Strain Description
Reference
JGY4

MATcclys2-801 his3-A200 leu2-3,112 ura3-52

M. Andrew Hoyt

Table 3. Plasmids used in characterization of yopO
mutation S406.
Plasmid Yeast markers
Bacterial
Reference
markers
pLN12
This study
CEN6 ARSH4 LEU2
bla fl
attBl
PGALl-YopO-V5attB2
6H-CYClterm
pJG4 84 CEN6 ARSH4 LEU2
This study
bla fl
attRl
PGAL1-V5-6HattR2 CmR ccdB
CYClterm
This study
pJG52 0
fl KmR attLl
attL2
This study
pLN5
CEN6 ARSH4 URA3
bla fl
attBl
PGALl-YopO-V5attB2
6H-CYClterm

Results
With this work we wanted to determine whether or not
expression of S406 was lethal in yeast and if it showed a
similar actin distribution and localization pattern as
YopO containing cells.

An examination of the protein
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expression profile was performed using a western blot.
Cells were grown overnight in S raffinose-leu media.
Raffinose was used as the sole carbon source for
overnight growth because it is a complex sugar and speeds
the transition from yeast using raffinose to galactose
and thus allows YopO to be produced more quickly.

Cells

were harvested beginning at time point zero and
continuing through hour 3.

Whole-cell protein extracts

were resolved on an 8% SDS polyacrylamide gel.

Proteins

were transferred to PVDF, and anti-V5 antibody was used
to visualize the S406 protein.

We were able to visualize

production of our protein beginning at two hours post
induction (Figure 2 ) .
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Figure 2.
W e s t e r n Blot a n a l y s i s of h a p l o i d y e a s t s t r a i n
JGY4 c o n t a i n i n g Y o p O m u t a t i o n S406 ( p L N 1 2 ) .
Samples were
g r o w n in S r a f f i n o s e - l e u m e d i a .
At h o u r z e r o , 2 % final
c o n c e n t r a t i o n of g a l a c t o s e w a s added to i n d u c e S 4 0 6 .
S406 w a s v i s u a l i z e d b y the V5 e p i t o p e at the C - t e r m i n a l
end.
O n c e w e e s t a b l i s h e d that S406 is p r o d u c e d w e
compare

lethality,

actin distribution and

p a t t e r n to c e l l s c o n t a i n i n g Y o p O .
containing

S4 0 6

can

localization

Haploid yeast

(pLN12) w e r e g r o w n o v e r n i g h t

strains

in

S r a f f i n o s e - l e u m e d i a and s e r i a l l y d i l u t e d o n t o S D - l e u
Sgal-leu media.

The S D - l e u m e d i a s e l e c t s

for

p l a s m i d , w h i l e the S g a l - l e u turns on the yopO
gene.

W h e n p l a c e d o n solid S g a l - l e u m e d i a the

t r u n c a t i o n d o e s g r o w , i n d i c a t i n g that the Y o p O
might not be c y t o t o x i c

(Figure 3 ) .

and

our
mutant
S406
truncation
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Sgal

SD
Control

.....

YopO

. ...f„

S406 I

• i Hninhion replica plating of haploid
Figure 3. Serial dilution repi
y ( p J G 4 8 5 ) , YopO
yeast strain JGY4 containing contro1 U?
d o n SD_
TpLN5) or S406 (pLKF12) . CelIs were r P
# Sgal_leu
(C
^
° n ^ e d I t P ? ° c ? o r four d a y - Each well is a 40
and incubated at JU U J-^J^
S i d dilution over the previous well.

further investigate this finding. we perfor.ed a

To

titer assay.

The titer assay allows us to grow cells

containing S406 without the inducer and then induce
expression of S406.
every

After induction, sables were taken

hour and serially diluted onto SD-leu plates to

exa.ine ability to recover frora any consequence of S406
expression.

are

rells that have survived the effects of S406
Cells cndi i

able to grow on SD-leu plates.

(Figure4)
l e t hal

The nu m ber of

. Using this assaywe found that

S ^ W e e a

and displays a sr.ilar phenotype as YopO.

The

difference between solid .edia and liquid m edia .ay be
explained by exa.ining expression of S40, .ore closely.

42

3.0E+07 A
£
"3
4-

(ft

"55
O

2.0E+07 A

SI
CO

>
£2

1.0E+07

1.0E+05
0

2

3

4

Time (hours)
Figure 4. Titer analysis of haploid yeast strain JGY4
containing control (pJG485), YopO (pLN5) or S406 (pLN12).
Cells were grown in Sraffinose-ura or Sraffinose-leu
medium respectively, since pJG485 and pLN5 contain a URA3
gene and pLN12 contains a LEU2 gene.
At hour zero,
galactose (2% final concentration) was added to the
medium, inducing expression of YopO.
Next we asked if S406 has an effect on the actin
cytoskeleton similar to YopO.

Expression of YopO causes

a loss of actin cables and a decrease in the amount of
actin cortical patches within the yeast cell. This
phenotype becomes evident by hour three of expression of
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full-length YopO.

S4 0 6 contains a functional Rho and Rac

binding domain, so our hypothesis was that S406 would
affect actin similarly as YopO.

Actin staining was

preformed as previously described in Nejedlik et
(2004) .

al.

The actin cytoskeleton in S406 containing cells

looks similar to cells containing the control plasmid
(Figure 5 ) . We saw no obvious effect of S406 on actin.
This is in contrast to YopO containing cells which by
hour three exhibit a loss of actin cables, and a decrease
in the amount of actin cortical patches in comparison to
cells containing the control plasmid (Figure 5 ) .

Control

YopO

S406

Figure 5. Actin distribution in haploid yeast strain
JYG4 containing an empty vector control (pJG485), YopO
(pLN5) or S406 (pLN12). Cells were grown in Sraffinoseura or Sraffinose-leu medium respectively, since pJG485
and pLN5 contain a URA3 gene and pLN12 contains a LEU2
gene. At hour zero, galactose (2% final concentration)
was added to the medium, to induce YopO expression. At

44
each hour, aliquots were taken and fixed with 3.7%
formaldehyde. Actin was visualized using RhodaminePhalloidin.

We also wanted to assay the effect this mutation had
on YopO localization.

To do this the V5 epitope was

again utilized for immunofluorescence imaging as
previously described in Nejedlik et al.

(2004).

The S406

protein does not localize to the cell periphery as seen
in cells expressing YopO.

S406 shows a more diffuse YopO

localization with distinct aggregation throughout the
cell (Figure 6 ) .

Control

YopO

S406

Figure 6. Localization of control, YopO or S406 in
haploid yeast strain JGY4. Cells were grown in
Sraffinose-ura (control, YopO) or Sraffinose-leu (S406).
At hour zero, galactose (2% final concentration) was
added to the medium, to induce YopO. At each hour,
aliquots were taken and fixed with 3.7% formaldehyde.
YopO and S406 were visualized utilizing the V5 epitope on
the C-terminal end of the gene.
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Discussion
Our hypothesis when beginning this work was that
S406 truncation would be lethal to yeast cells,
indicating that the actin and Rho binding domains are
essential for lethality.

Also, we expected that actin

distribution would be effected similarly to YopO, in that
we would observe a loss of actin cables and a decrease in
the amount and intensity of cortical patches over time.
We also expected that localization of S406 would occur at
the cell periphery as in YopO.
We were able to show that S4 06 is indeed lethal
using the titer assay. By hour three, only 9% of cells
containing the S406 mutation are still viable, in
comparison only 3% of cells containing YopO are still
viable.

These results indicate that the actin and Rho

binding domains are essential for lethality, however the
kinase domain is not which is in complete agreement with
the results of Nejedlik et al. (2004).

Although recent

research has found that the kinase is essential for
inhibiting Gaq, Gaq is a subunit of G proteins which are
involved in a variety of signaling pathways (Navarro et
al.,

2007) . It appears as though this function is not

essential for YopO lethality in yeast.

Our finding that

the kinase domain is not essential for lethality is in
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agreement with the fact, that YopO does not phosphorylate
either Rho or actin (Juris et al.,

2000) and indicates

that YopO must exert its effect over these proteins by
another means.
The difference in the serial dilution versus the
titer assays could be explained by further examining the
expression of S406 via a Western blot.

One possible

explanation for the difference between the two assays
could be that following maximal expression of S406, the
expression begins to decrease.

In our titer assay we

only continue through hour 3; the time at which maximal
expression occurs.

However, in the serial dilution

assay, cells are grown for two days on solid medium.
These cells may be able to grow after YopO expression
begins to decrease.

Further examination of this

phenomenon needs to be carried out to fully understand
the differences.
Previously our lab had discovered that YopO has an
effect on the actin cytoskeleton.

In order to understand

the effect that YopO and any YopO mutations have on the
yeast cell, we must first understand wild type actin
distribution in the cell.

Within the yeast cell, actin

is normally seen in three different structures, actin
patches, cables and the actomyosin contractile ring
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(Moseley and Goode, 2006).

The actomyosin ring, is only

present transiently and hard to image.

Although actin

patches have a short life span, they are present
throughout the cell cycle (Moseley and Goode, 2006) and
therefore much easier to image.

The function of these

patches seems to be tied to endocytosis.

Yeast cells

treated with a chemical known to effect actin monomers
were found to have a problem in the uptake of Lucifer
Yellow tagged liquid (Ayscough et al,
defect in endocytosis.

1997) , indicating a

The function of actin cables are

to direct bud growth, and are needed for polarized bud
growth.

Cables are also responsible for transport of

organelles and vesicles needed for proper cell division
(Moseley and Goode, 2006) .
Actin distribution in cells containing the S406
mutation is similar to strains containing the control
plasmid.

We consistently see actin cortical patches and

actin cables throughout all time points.

YopO containing

cells exhibit a loss of actin cables and a decrease in
the amount of actin cortical patches by hour three post
induction.

This result is rather surprising, given that

this mutation is still lethal.

One would presume that in

order to cause this lethality, YopO would be interacting
with Rho or the actin cytoskeleton, however we are not
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seeing any obvious changes in the cytoskeleton.

This

finding could be explained by the fact that cells
containing the S406 mutation do not localize to the cell
periphery as YopO does.

If in fact, YopO is causing

lethality by binding actin or Rho to disrupt the
cytoskeleton, one would think that YopO would need to
localize where those proteins are located.

However S406

exhibits a scattered localization pattern, with
aggregation occurring throughout the cell.

These patches

do not obviously localize with a particular organelle or
structure we can identify within the cell.

Two

possibilities could explain these results.

Either

lethality is not strictly being caused by YopOs
association with either actin or Rho, since these two
proteins are not present in the same location as YopO,
and there is no obvious effect on the cytoskeleton or
maybe only a small amount of YopO is needed to exert an
effect on Rho.

In the latter case, we may not be able to

visualize such a small amount of YopO present at the cell
periphery.
We have shown that S406 does not localize to the
cell periphery as we saw previously with YopO.

S406

exhibits, localization scattered in patches throughout the
cell.

These patches do not seem to co-localize with any

49
obvious organelle we can identify within the cell.

The

finding that YopO does not localize to the membrane in
this mutant is in agreement with the fact YopO contains a
chaperone binding and membrane localization domain in the
N-terminus of the protein (Letzelter et al.,

2006) .

region of the protein is absent in our mutant.

This

Our

results indicate that there is no additional region
located in the C-terminus needed for localization and the
C-terminus alone is sufficient for lethality.
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CHAPTER 4
TWO-HYBRID SCREEN
Introduction
The overall goal of our study is to use yeast as a
model system for identifying the cellular targets of
YopO. A two hybrid screen allowed us to use YopO as bait
to determine which of the library prey plasmids contains
a protein with which it interacts.

This approach allows

us to assess the cellular targets of YopO without bias.
In carrying out this screen, we used a yeast genomic
library to search for targets of YopO.

Our goal when

carrying out this study was to identify not only the
known targets of YopO, Rhol and RacA (Bartz et al., 1996,
Dukuzumuremyi et al.,

2000) as a target of YopO, but also

identify new targets.
However, we were unable to identify any cellular
targets of YopO using the two-hybrid screen.

Our results

indicate that the two hybrid screen may not be an
effective tool to identify the cellular targets of YopO.
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Materials and Methods
Media
All yeast media (YPD, SD-leu, SD-ura, SD-ura-leu,
Sgal-ura, Sgal-leu, and Sgal-ura-leu) were prepared as
previously described (Guthrie and Fink, 1991).

LB media

(LB + ampicillin) were prepared as previously described
(Sambrook and Russell, 2001) .
Plasmid Creation
The GATEWAY™ Vector Conversion System (Invitrogen)
was used to create plasmid pLN2.

Vector pASl-CYH2 was

digested with Smal, followed by ligation in the presence
of 50ng of reading frame B, 2ul 5X T4 DNA ligase buffer,
lul T4 DNA ligase at 16°C overnight.

The ligation was

transformed into DB3.1 competent cells.

DB3.1 cells were

used because they are resistant to the lethal effects of
the ccdB gene that is present in the vector. Colonies
were selected on LB plates containing chloramphenicol.
The resulting colonies were grown overnight and prepped
using the alkaline lysis miniprep (Sambrook and Russell,
2001) as previously described.

The resulting plasmid,

pLN2, was used to proceed with the GATEWAY™ LR reaction
with plasmid pLN3 to create pLN6 (Table 5 ) . Plasmid pLN6
contains a LEU2 marker as well as a full length copy of
YopO.
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Screen
This screen was carried out as originally described
in Chien et al.

(1991).

Haploid yeast strain JGY80 (Table 4) was transformed
as described (Gietz and Schiestl, 1991) with pLN6 and one
of three libraries (Y2HL-C1, Y2HL-C2 or Y2HL-C3).
Transformation efficiency was assessed by plating yeast
on media lacking tryptophan and leucine (WL). The
remaining transformants were plated onto media lacking
tryptophan, leucine, and histidine (WLH).

Once colonies

had formed on these plates, yeast were replica plated
onto media lacking tryptophan, leucine, and adenine
(WLA).

Positive colonies were restreaked and genomic DNA

was extracted using the Guanine hydrochloride(GuHCL)
yeast genomic DNA prep.
GuHCL Yeast Genomic Prep
A 10 ml culture of the appropriate yeast strain was
grown overnight at 30°C and then pelleted at 2000 rpm for
5 minutes.

Cells were washed in 1 ml dH20 and

centrifuged again for thirty seconds.

The liquid was

aspirated and cells were resuspended in 150 pi SCE, lul
[3-Mercaptoethanol, 3 ul zymolyase.

Cells were incubated

at 37°C for one hour then centrifuged for 2 seconds.

The

supernatant was aspirated and the pellet resuspended in
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150 pi GuHCL.

Cells were incubated at 70°C for 10

minutes after which time they were allowed to cool at
room temperature for five minutes.

After cooling 150ul

of ice cold 100% ethanol was added and vortexed.

Cells

were centrifuged for 5 minutes and the supernatant was
removed.

The remaining pellet was allowed to dry at room

temperature for 10 minutes.

The pellet was then

resuspended in 300 ul lOx TE pH 8.0, and 500 ul
phenol/chloroform/isoamyl alcohol.

The tube was vortexed

then centrifuged for five minutes.

After centrifugation

the .supernatant was removed to a new tube and 1/10 volume
of 3 M NaOAc, pH 5.2, and two volumes of 100% ethanol was
added.

The tube was inverted 3-4 times and placed in the

-20°C freezer overnight.

The DNA was then pelleted by

centrifugation for 10 minutes.

The supernatant was

removed and the pellet was dried at 3 7°C.

Once dry the

DNA was resuspended in 300 ul dH20.
Isolation of Library Plasmid
Genomic DNA was transformed into electrocompetent
XL-1 Blue cells.

Colonies were grown overnight and an

alkaline lysis miniprep was performed

Russell, 2001) .

(Sambrook and

Four colonies in total were examined

from each electroporation, to ensure that all constructs
were the same.
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Analysis of Positive Interactions
The isolated plasmid was transformed back into
strain JGY8 0 containing pLN6.

Yeast transformants were

restreaked and then grown overnight in S raffinose-trpleu medium.

These cultures were serially diluted onto

SD-trp-leu, SD-trp-leu-his, and SD-trp-leu-ade media and
growth was assessed.
Table 4.

Yeast strain used in two-hybrid study.

Strain

Chromosomal

Reference

JGY80

MATa his3-200 leu2-3,112 trpl-901 ura3-52 gal4 gal80
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ

This study

Table 5.

Plasmids used in two-hybrid study.

Plasmid

Yeast

Markers

Bacterial
Markers

pLN2

2 m i c r o n TRP1
CYH2 PADHGAL4 ( 1 - 1 4 7)

CmR ccdB
attR2
bla

pLN3
pLN6

Y2HL-C1

Y2HL-C2

Y2HL-C3

2 m i c r o n TRP1
CYH2 PADHGAL4 ( 1 - 1 4 7) -YopO
2 m i c r o n LEU2
PADH1-GAL4-ADTADH1
2 m i c r o n LEU2
PADH1-GAL4-ADTADH1
2 m i c r o n LEU2
PADH1-GAL4-ADTADH1

Reference
This

study

Fl KmR attLl
attL2
attBl
attB2
bla

This

study

This

study

bla

J a m e s e t al. ,
1996

bla

J a m e s e t al. ,
1996

bla

J a m e s e t al. ,
1996

attRl

55
Results
This screen was carried out as previously described
in Chien et

al.,

1991.

We transformed YopO into strain

JGY80 along with one of the three libraries (Y2HL-C1,
Y2HL-C2, and Y2HL-C3).

These libraries were constructed

from yeast genomic DNA by James et al.,
represent each reading frame.

(1996) and

In order to construct each

reading frame a single base pair was added to the
plasmid, thus changing the reading frame.

From each

library we checked one million colonies of independent
yeast transformants to ensure a high likelihood that we
examined every construct in the library.
To test for potential interactions, transformants
were plated onto plates lacking trp-leu-his (WLH).
lacking WLH was used first because the his3
yeast can be leaky.

Media

marker in

Yeast that grew on these plates,

were replica plated onto plates lacking trp-leu-ade
(WLA), which allows for tighter regulation.

Yeast that

also grew on these plates were deemed potential positive
interactions (Table 6 ) . To retest the interaction,
strains were screened for those-able to lose the YopO

plasmid.
with YopO.

The resultant strains were then retransformed
Transformants were grown overnight and

serially diluted onto media lacking, trp-leu (WL), WLH
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and WLA respectively.

The use of media lacking WL,

ensures that yeast contain both the YopO and library
plasmid.

The use of WLH and WLA media tests for the

interaction between YopO and the library plasmid.

After

this process we did not find any positive interactions
between YopO and the library plasmid.
Table 6. Two-hybrid transformations and positive
colonies.
Colonies
checked
Positive
colonies
Actual
positives

Y2HL-C1
1,030,000

Y2HL-C2
1,694,000

Y2HL-C3
1,100,000

71

76

165

0

P

0

Discussion
The yeast two hybrid screen has been employed by
several other laboratories to elucidate the targets of
effector proteins.

The two-hybrid was used to find the

targets of Shigella

effector protein IpaC (Yao et

2003).

This study determined that RanBMP interacts with

IpaC and may be a target (Yao et al.,
al.

al.,

2003).

Jackson et

used the two hybrid screen to determine which Ysc

proteins interacted to create the injectisome (Jackson et
al.,

2000).

Francis et al.

(2000) were also able to use

the two hybrid screen to determine that YopD and LcrH
interacted.

The two hybrid screen has already been used
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to identify Racl as a target of YopO (Barz et al. , 2000).
Their screen utilized a HeLa cell library to screen for
interactions, whereas our screen uses a yeast library.
The two hybrid screen in yeast has been a valuable tool
in determining cellular interactions between proteins.
Here we employ the system to identify the cellular
targets of YopO.
In this screen, a bait plasmid is used and
interactions are tested with unknown proteins via a
library.

The bait plasmid, in our case YopO, is fused to

the Gal4 DNA binding domain, while the prey plasmid, the
library, is fused to the activation domain.

If the two

proteins interact, a functional transcription factor is
assembled and transcription of a reporter gene occurs.

A

functional transcription factor allows for transcription
of three reporter genes HIS3,

LEU2 and la.cZ.

If they do

not interact, a functional transcription factor is not
assembled, and thus no reporter gene transcription
occurs.
al.

This assay was originally developed by Chien et

(1991).
Our two-Hybrid screen was not successful in

identifying any potential targets of YopO.

Previous

literature had indicated that YopO can bind RhoA and Rac,
but not Cdc42 (Barz et al.,

2000, Dukuzumuremyi et

al.,
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2000 and Juris et al.,

2000). Our goal with this study

was to at least identify the yeast homologs of these
targets of YopO.
There are several potential reasons we have not been
able to find positive interactions.

First, previous

literature had identified Racl as a target of YopO using
the two hybrid screen.

This screen used a HeLa cell

library instead of a yeast library.

This is a key

difference between our two screens.

There may not be

enough homology between the two proteins for YopO to
interact with yeast Rho proteins.

YopO may be exerting

its effect through a different mechanism in yeast.
Second, the two hybrid system takes place within the
nucleus, and we have shown through immunofluorescence
that YopO does not localize in the nucleus.

Also, the

Rhos and Cdc42 are not sequestered in the nucleus either,
and undergo significant posttranslational modification in
the cytoplasm, which allows them to be anchored in the
membrane. Conceivably this attachment to the membrane may
need to occur before YopO can exert its effect,
especially since YopO is localized to the membrane by its
membrane localization domain. Simply, YopO may not be
able to exert an effect on Rho when it is sequestered in
the nucleus.

Third, the two hybrid system does not allow
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for transient interactions, maybe YopO and Rho do
interact, however the interaction is fleeting.

Although,

if YopO does function as a RhoGDI (Guanidine nucleotide
dissociation inhibitor) as previously described (Prehna
et al.,

2006) a transient interaction should not be the

case.

To prevent the release of GDP by associating with

the switch region, or covering the isoprenyl group in
order to leave Rho in the cytosol, would require a much
longer interaction.

We have completed our two-hybrid

screen and have deemed it not useful in identifying
cellular targets of YopO.
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CHAPTER 5
ISOLATION OF SUPPRESSORS OF YOPO IMPOSED LETHALITY
Introduction
Previous targets of YopO have been identified using
two-hybrid and co-immunoprecipitation studies.

Work

using the two-hybrid system utilized a HeLa cell library
(Barz et al.,

1996) or direct PCR amplification of RhoA

to show an interaction.

Mammalian RhoA, Racl and Cdc42

were used in the co-immunoprecipitation study (Barz et
al.,

1996)
Our goal is to identify cellular targets of YopO and

genes required for YopO imposed lethality of yeast.

We

generated spontaneous revertant yeast strains that can
grow in the presence of YopO expressed from the GAL1
promoter.

This screen allows us to search for genes that

relieve the YopO lethality without bias for what we
expect to find, and will hopefully identify within the
collection of suppressors, genes whose protein products
are cellular targets of YopO.
With this screen we were able to identify 11
spontaneous revertants of YopO.

We were able to

characterize these suppressors by assessing their growth
on galactose media, determining if they were able to

61
suppress different yop genes, and examine the sporulation
pattern.
Materials and Methods
Media
All yeast media (YPD, SD-leu, SD-ura, SD-ura-leu,
Sgal-ura, Sgal-leu, and Sgal-ura-leu) were made as
previously described Guthrie and Fink (1991) .
Sporulation media was made using 1% potassium acetate,
0.1% yeast extract and 0.05% glucose (Dumlao et

al.,

2008) .
Transformation
Transformations of yeast strains were performed as
previously described (Gietz and Schiestl, 1991) .
Creation of Suppressor Strains
Diploid yeast strain 709 (Table 7) was cotransformed with plasmid pLN5 (YopO, URA3) and pLN12,
(S406 LEU2)

(Table 8 ) . We isolated independent

transformants which were then grown in S raffinose-uraleu media.

Raffinose was used as the sole carbon source

to speed the transition to utilizing galactose as the
carbon source.

Yeast strains were plated at a

concentration of 107 cells onto Sgal-ura-leu to turn on
expression of YopO.

Half of the resulting plates were
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placed at room temperature and the other half at 30°C.
Plates were allowed to grow for one week at their
respective temperature.
Sporulation
Strains were grown for at least 5 days in 5ml
sporulation media at room temperature with rotation.
After 5 days, 1 ml samples of each strain were taken.

To

these samples 3 ul of Zymolyase was added followed by
incubation for 10 minutes at room temperature.

This

allowed for weakening of the spore ascus so separation of
individual spores would occur.

Once completed, 30 ul of

digested sample was pipetted onto the middle of a YPD
plate.

The sample was dissected under a Nikon Eclipse

E400 microscope.

Sporulation and dissection procedure

was carried out as described in Guthrie and Fink, 1991.
Table 7. Yeast strains used in suppressor study.

Strain Chromosomal
JGY7 09 MATa/MATa
ade2-101/ADE2
LYS2/lys2-801
his3-200/his3—
200
Ieu2-3,112/leu2-3,112
ura3-52/ura3-52

Reference
M.Andrew Hoyt
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Table 8. Plasmids used in suppressor study.
Plasmid Yeast Markers
Bacterial
Markers
pLN5
CEN6 ARSH4 URA3
bla fl
attBl
PGALl-YopO-V5-6HattB2
CYClterm
CEN6 ARSH4 LEU2
bla fl
attBl
pLN!2
PGALl-YopO-V5-6HattB2
CYClterm

Reference
Nejedlik et
al.,

2004

This study

Results
To execute this screen we first transformed JGY709
(Table 4) with two YopO plasmids.

Two plasmids were used

to ensure that the mutation we isolated was not in the
plasmid, but in the yeast genome.

If a mutation were to

occur in on plasmid, in for example, the galactose
promoter, the other plasmid would still be functional.
The two YopO plasmids we used were YopO (pLN5) and S406
(pLN12) (Table 5 ) . These plasmids possessed the URA3 and
LEU2 markers respectively.

The S406 plasmid contains

only the C-terminal portion of YopO, from amino acid 406720.

Yeast that contained these two plasmids were plated

on media containing 2% final concentration of galactose
and lacked uracil and leucine.

Yeast placed on this

medium are not able to grow due to YopO lethality, but
our screen was designed to identify strains that had
picked up a mutation and were able to suppress the YopO
effects.
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We began the screen with 60 independent
transformants.

The strains were plated onto Sgal-ura-leu

media and placed at room temperature or 3 0°C.

A lawn of

growth occurred on most (26/30) plates placed at 30°C and
9/30 plates at room temperature; these plates were
discarded.

From the remaining 25 plates, we picked 10

colonies from each plate and confirmed all markers were
correct. All potential suppressor strains were processed
to allow isolation of strains lacking both plasmids.
These were constructed so that we could test our
assumption that our screen would not identify suppressors
which occurred by mutation of the plasmids. Following
isolation of strains lacking both plasmids, each strain
was retransformed with pLN5, plated onto SD-ura and grown
at room temperature.

All 250 strains checked for

continued YopO lethality were replica plated and the best
suppression candidates were chosen.

These strains were

chosen because of their robust growth on Sgal-ura media.
Eventually the pool of potential suppressors was narrowed
to 12. These suppressors were named SypO-1 through SypO11.
Once potential suppressors had been identified we
then assayed for suppression activity against YopT and
YopE (Table 9 ) . This was done to further characterize our
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suppressor strains, and allowed us to see if they could
suppress more than one Yop.

Only one suppressor, SypO-6,

was YopO specific and one suppressor, SypO-7, suppressed
YopO and YopT.
and YopT.

All of the others suppressed YopO, YopE

This finding is not surprising since these

three Yops are known to have effects upon the
cytoskeleton and may have the same or similar targets
that they disrupt.

These suppressors may have identified

a genetic pathway that is acted on by more than one Yop.
Table 9.

YopO suppressor specificity.
YopO
YopE
X
X
SypO-1
X
X
SypO-2
X
X
SypO-3
X
X
SypO-4
X
X
SypO-5
X
SypO-6
X
SypO-7
X
X
SypO-8
X
X
SypO-9
X
X
SypO-10
X
X
SypO-11

X= suppression
YopT
X
X
X
X
X
X
X
X
X
X

To begin characterizing the suppressors, we forced
them to sporulate on liquid sporulation media.
the suppressors had growth of all 4 spores.

Six of

Several

suppressors, SypO-3, 4, 8, and 10, when dissected, only
had two of the four spores alive (Table 10). All strains
were characterized to make sure appropriate markers and

mating types were correct.

Strains were then frozen at -

80°C for further characterization.

SypO-5 was found to

require a LEU2 marker on a plasmid during our
characterization and was not pursued further.
was found to have a mutation in the lys

SypO-12

gene and was not

examined further.
Table 10.

SypO-1
SypO-2
SypO-3
SypO-4
SypO-5
SypO-6
SypO-7
SypO-8
SypO-9
SypO-10
SypO-11
SypO-12

Results of suppressor dissections.
Number of
Viable Spores
4
4
2
2
2
4
4
2
4
2
4
4

All diploid and haploid suppressor strains isolated
had been frozen for storage purposes at -80°C.

When

strains were allowed to thaw and assayed for suppression
of YopO, no strains retained the phenotype.

Recovery of

these strains were tried using several different methods.
First, we checked a large number of YopO transformants
from each strain by replica plating from SD-ura to Sgalura media. Our hope was to find a small population of
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yeast that still suppress the YopO phenotype present in
the sample.

Secondly, we tried removing samples from the

freezer onto YPD or SD-complete media to ensure it was
not the media causing loss of suppression.

Thirdly, we

also tried transforming both YopO and S406 and replica
plating all transformants from SD-ura-leu onto Sgal-uraleu.

With this approach we had hoped that by recreating

the conditions under which we isolated the suppressors
originally, we could find a small population of yeast
that suppressed YopO lethality.

None of these methods

were successful at recovering any suppressor strain.
Discussion
The suppressor assay we developed was successful in
producing suppressors of YopO imposed lethality. However,
we ran into several problems when characterizing these
strains.

First, we were not able to isolate haploid

yeast strains that contain our suppressor mutation in the
majority of yeast strains.

Second, several suppressors

only produced two viable spores instead of four under any
conditions.

Third, our mutant strain lost the ability to

suppress YopO when frozen for storage.

Upon sporulation of SypO-6, 7, 9, 11 we were able to
recover four viable spores.
spores able to suppress YopO.

We expected to find two
When we assayed these four
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spores for suppression of YopO, we did not find any that
could suppress YopO.

This was a surprising finding in

such a larger number of strains, four out of eleven.

One •

could expect a random meitotic event resulting in no
spores able to suppress YopO, to occur in one, but not
six strains.
With suppressor strains SypO-3, 4, 8, and 10 we
found that only two spores were viable, regardless of
dissecting them with S406 or without plasmid.

This

result was not to surprising, as the mutation could be in
an essential gene.

This mutation could be a loss-of-

function mutation, leaving the essential gene
nonfunctional, thus rendering the two spores with the
mutation inviable.

This hypothesis would make sense,

since YopO must be interacting with an essential gene to
cause lethality.
The other obstacle we ran into was the loss of our
suppressor phenotype when all strains were frozen for
storage.

This phenomenon was fairly surprising, since

strains are routinely frozen without incident.
Suppressor strains were frozen without a YopO containing

plasmid.

After thawing, strains were transformed with

YopO and rechecked for suppression, it was at this time
strains no longer suppressed.

There are several
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hypotheses that could explain this result including
adaptation, phenotypic plasticity, or cells containing
the suppressor mutation did not survive freezing but a
small subset of non-mutated cells were present and did
survive.
If we were to do this assay again there are several
things we would do to ensure survival of the strain.
First, strains would be frozen with and without the YopO
plasmid present.

Second, before discarding the original

strain after freezing, frozen strains would be thawed and
checked for suppression.

Third, alternative methods of

storing suppressor strains could utilized, for example
long term storage on plates by restreaking, or using
slants.
Had we been able to recover haploid yeast strains
that contained our suppressor, and been able to preserve
the strains, we would begin searching for ways to further
characterize these strains.

To do this, we would perform

titer assays on all haploid yeast strains.

This would

allow us to further characterize the change in YopO
lethality observed with these strains.

We would also

look at actin distribution in these strains to see if
YopO is still able to affect actin by causing a decrease
in the amount of actin cortical patches and a loss of
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actin cables.

In addition to looking at actin

distribution, we could also look at YopO localization to
see if localization still occurs at the cell periphery.
We could also use the haploid yeast strains to perform a
linkage analysis.

We would mate each haploid yeast

strain together to produce a diploid strain.
strain would be sporulated and dissected.
would be assayed for YopO lethality.

The diploid

The spores

If all four spores

are able to suppress YopO lethality, we know that those
suppressor mutations are on the same chromosome.

If all

four spores do not suppress YopO, then we know those
mutations must be on separate chromosomes.

All of these

assays will help us to put all of our suppressors into
groups and narrow down our search.
Once we have narrowed down our suppressor field even
further, we would have been able to begin searching for
an additional phenotype associated with YopO suppression.
The easiest phenotype we would look for would be
temperature sensitivity,.

We would be looking for strains

that would suppress YopO lethality at room temperature,
but would be lethal at higher temperatures like 37°C.

This would allow us to transform a yeast library into
suppressor strains and search for transformants that
suppressed YopO at the restrictive temperature.

The

library plasmid could then be isolated and sequenced t
determine the genes present.

Once we have determined

gene present in the library plasmid, we could go back
sequence the appropriate gene in the yeast genome to
determine the exact mutation that causes suppression o
YopO lethality.
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CHAPTER 6
CO-IMMUNOPRECIPITATION
Introduction
Previous literature indicated that RhoA and Racl are
targets of YopO (Dukuzumuremyi et al.,

2000).

We used

this knowledge to examine if yeast Rhol-3, Rho5 and Cdc42
are targets of YopO in yeast.
immunoprecipitation assay.

To do this, we used a co-

Co-immunoprecipitation will

allow us to determine if S406, a YopO truncation that
contains only amino acids 406-720 and Rhol-3, Rho5 and
Cdc42 are able to interact.
With this assay we found that Rhol-3, Rho5 and Cdc42
bind YopO either directly or in complex.

We confirmed

this finding by precipitating the complex using YopO or
Rho proteins.
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Materials and Methods
Media
All yeast media (YPD, SD-leu, SD-ura, SD-ura-leu, Sgalleu, Sgal-ura-1'eu) were prepared as previously described
(Guthrie and Fink, 1991).
Plasmid Creation
pLN12 was created as previously described in chapter
III. Rho plasmids were purchased from OpenBioSystems
(Table 12) .
Trans formation
Yeast strain JGY4 (Table 11) was transformed as
previously described (Gietz and Schiestl, 1991) .

Strain

JGY4 was co-transformed with pLN12 (S406) and either
Rhol-3, Rho5 or Cdc42.

These strains were grown on SD-

ura- leu media at room temperature for maintenance of both
plasmids.
Culture Preparation
Strains were grown overnight at 3 0°C with shaking in
S raffinose-ura-leu media, final concentration of 2%
raffinose. Cultures were diluted to 30 Klett in S
raffinose-ura-leu media.

These cultures were allowed to

grow at 3 0°C with shaking to mid log phase, around 5 0
Klett, at which time they were induced with galactose at
a final concentration of 2%. , Strains were allowed to
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grow for three hours post induction at which point 15 ml
samples of each strain were collected.
Phenylmethanesulphonylfluoride

(PMSF) was added to a

final concentration of 1 mM, to inhibit proteases.
Samples were washed with 1 ml of water, and centrifuged
in a microfuge.

The resulting pellet was stored at -80°C

until ready for use.
Sample Preparation
Cells were resuspended in 400 ul of GFO with
protease cocktail.

GFO contains 50 mM Tris pH 8.0, 150

mM NaCl, 2 mM MgCl2 and 0.2% Tween 20.

The protease

cocktail consists of a final concentration of 1 mM PMSF,
1 ug/ml pepstatin and 1 ug/ml leupeptin.

To this

mixture, y2 volume of acid-washed glass beads were added.
The samples were then bead beat using a vortex at 3 0
second intervals for 10 minutes to break down the cell
wall.

Bead beating occurred at 4°C and samples were

placed on ice in between.

After bead beating, samples

were centrifuged for 10 minutes in a microcentrifuge at
13 000 rpm.

The supernatant was removed and placed in a

fresh eppendorff tube.

To this sample the appropriate

antibody was added, either anti-HA for the Rho constructs
or anti-V5 for YopO and incubated on ice for one hour.
After incubation, 50 ul of IgG sepharose beads (Amersham
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Pharmacia) were added to each sample.

The IgG sepharose

beads had been washed 4x with 1 ml GFO.

The samples were

allowed to incubate at 4°C with rocking for a minimum of
one hour.

Samples were then spun down in a microfuge for

5 minutes at 3-4000 rpm.

Both the pellet and supernatant

were saved for analysis by Western Blot.
Western Blot
Western Blotting was carried out as previously
described in Nejedlik et al.,2004.

The only difference

was that visualization of Rho proteins via the HA epitope
required anti-rabbit HRP conjugated secondary antibody
instead of anti-mouse.
Table 11. Yeast strain used in Co-immunoprecipitation
study.
Strain Description
Reference
JGY4

MATa lys2-801
his3-A200
3,112
ura3-52

leu2-

M. Andrew
Hoyt
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Table 12. Plasmids used in Co-immunoprecipitation study.
Plasmid Yeast markers
Bacterial
Reference
markers
CEN6 ARSH4 LEU2 bla fl
This study
pLN12
attBl
PGAL1-S4 06-V5attB2
6H-CYClterm
pRhol
URA3 pGallbla attbl
attb2 OpenBioSysterns
Rhol-6H-HA
pRho2
URA3 pGallbla attbl
attb2 OpenBioSysterns
Rho2-6H-HA
pRho3
URA3 pGallbla attbl
attb2 OpenBioSysterns
Rho3-6H-HA
pRho5
URA3 pGallbla attbl
attb2 OpenBioSysterns
Rho5-6H-HA
pCdc42
URA3 pGallbla attbl
attb2 OpenBioSystems
Cdc42-6H-HA
Results
Our goal when undertaking this study was to
determine if Rhol, Rho2, Rho-3, Rho5 or Cdc42 bind
physically to YopO.

Previous literature had indicated

that mammalian RhoA and Racl bound to YopO but not Cdc4 2
(Dukuzumuremyi et al.,

2000) .

In yeast Rhol is

homologous to RhoA and Rho5 is homologous to Racl.
We co-transformed either Rhol-3, Rho5 or Cdc42 with
S406 into JGY4.

S406 is a truncation mutation of YopO

that produces only amino acids 406-720.

This allowed us

to induce over-expression of Rho as well as S406, and
assay if the two proteins interacted.

We performed the

co-immunoprecipitation two ways, either by precipitating
the protein complex using Rho or by using YopO.
this as a control to verify our results.

If

We did
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precipitating with Rho, anti-HA antibody was added to the
whole cell extracts, because the Rho constructs have a HA
epitope at the C-terminal end of the protein.

If

precipitating with S406, anti-V5 was added to the whole
cell extracts.

After incubation, IgG sepharose beads

were added in order to bind the antibody present in the
sample.

Extracts were then centrifuged to pellet the IgG

sepharose beads and both the pellet and supernatant were
resolved by SDS PAGE and transferred to a PVDF membrane.
The PVDF was incubated in either anti-rabbit HRP
conjugated antibody for Rho or anti-mouse HRP conjugated
antibody for YopO.

The membrane was then developed per

protocol (Amersham Biosciences).
First, looking at the co-immunoprecipitation done
using Rho to precipitate S406, we were able to see all
Rhos and Cdc42 present in the supernatant as expected and
also in the pellet.

This indicates that S406 is able to

interact within a complex with each of the Rhos and Cdc42
we tested (Figure 7 ) . In order to confirm this finding,
we performed the opposite experiment, which is
precipitate the complex using S406, and visualize Rho
(Figure 8 ) . We again saw that all Rhos were present in
the supernatant and the pellet.

Confirming that S406

does interact with all Rhos we tested.
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An interesting result we observed is that Rho5 which
based on predicted size should migrate at 36 kDa,
migrated at 4 7 kDa.
expected.

This is considerably larger than we

To investigate this finding we prepared whole

cell extracts from yeast strains only containing Rho5 and
resolved them on a polyacrylamide gel.

Proteins were

then transferred to PVDF and incubated with anti-HA
antibody.

Anti-rabbit HRP conjugated antibody was used

as the secondary antibody.

Rho5 was again observed

around 47 kDa (Figure 9 ) . Suggesting that Rho5 does
indeed migrate at 47kDa, and our original blot is
correct.

Rhol
S P

Rho2
S
P

Rho3
S
P

Rho5 Cdc42
S
P S P

175
83
62

47

32

25
16,

Figure 7. Immunoprecipitation using Rho to precipitate
S406. Samples were grown in Sraffinose-ura-leu media. At
hour zero, 2% final concentration of galactose was added
to induce S406 and Rhol-3, Rho5 and Cdc42 expression.
The HA tag at the C-terminal end of Rho was utilized to
pull down Rho using IgG sepharose beads. S4 0 6 was
visualized using the V5 epitope. S=supernatant P=pellet
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Figure 8. Immunoprecipitation using YopO to precipitate
Rhol-3, Rho5 and Cdc42. Samples were grown in S
raffinose-ura-leu media. At hour zero, 2% final
concentration of galactose was added to induce S406 and
Rhol-3, Rho5 and Cdc42 expression. The V5 tag at the Cterminal end of S406 was utilized to pull down S406 using
IgG sepharose beads. Rhol-3, Rho5 and Cdc42 were
visualized using the HA tag. S=supernatant P=pellet
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Figure.9. Western blot of Rho 1-3 and Rho5. Samples were
grown in Sraffinose-ura-leu media. At hour zero, 2%
final concentration of galactose was added to induce
Rhol-3, and Rho5 expression. The HA tag at the Cterminal of Rho was used to visualize these constructs.
l=Rhol, 2=Rho2, 3=Rho3 and 5=Rho5
Discussion
Our overarching goal throughout this research has
been to identify the target(s) of YopO using the twohybrid screen and suppressor analysis.

The purpose of

these screens was to find novel targets of YopO and our
hope was to confirm previously reported targets.

It

allowed us to screen for targets unbiased by preexisting

82
knowledge.

We discovered that the two-hybrid screen

(chapter 4) was not a useful tool to identify the targets
of YopO, and we encountered several problems with the
suppressor screen (chapter 5 ) .

Co-immunoprecipitation

has allowed us to use our knowledge that RhoA and Racl
bind YopO (Barz et al.,
2000).

1996, Dukuzumuremyi et

al.,

We used this knowledge to screen the yeast Rhol-

3, Rho5, and Cdc42 for interaction.
With this assay we were able to show that S406 which
contains the C-terminal portion of YopO from amino acid
406-720, interacts with Rhol-3, Rho5 and Cdc42.
a homolog of mammalian RhoA (Madaule et al.,
Rho5 is a homolog of mammalian Racl.

Rhol is

1987) and

Previous work had

shown that full length YopO interacts with RhoA and Racl
(Barz et al.,

1996, Dukuzumuremyi et al.,

2000).

This

work shows that only amino acids 4 06-72 0 are needed for
this interaction. Previous work had shown that YopO does
not interact with Cdc42 (Barz et al.,

1996), however in

our study we show that S4 06 does in fact interact with
Cdc42.

This could be due to the fact that we are using

yeast Cdc42 instead of mammalian Cdc42.

Also, previously

full length YopO had been used, in our study we are only
using a small piece.

It could be that additional domains
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in the N-terminal portion of the protein are inhibiting
the interaction of Cdc42.
We were able to confirm these results using S406 to
precipitate the Rho constructs, or by doing the reverse,
using Rho to precipitate S406.

The interesting thing

about these blots, is that both of them look identical.
This should not be the case, since we are using two
different antibodies to visualize these proteins.

To

visualize YopO, we use anti-mouse HRP conjugated
secondary antibody and to visualize Rho we use antirabbit HRP conjugated secondary antibody.

Therefore if

there was a mix up with the secondary antibodies, we
would not see any bands present.

These results could be

explained by the fact that YopO and each of the Rhos are
covalently bound, and therefore are not separated by
denaturing, but the band sizes observed are not large
enough for this to be the case.

Currently, more work

needs to be done to further elucidate these findings.
The co-immunoprecipitation assay does not tell us
which interactions are the most important or biologically
relevant.

Nor does it tell us all of the proteins S40S

interacts within the cell.

Also to perform the co-

immunoprecipitation, both YopO and Rho proteins are over
expressed within the cell, well above physiological
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conditions but not above our lethality assay conditions.
This could result in a more robust interaction than would
normally be seen in the cell.

Co-immunoprecipitations

also do not take into account that other proteins may be
mediating the interaction between S406 and Rho.

Because

of these limitations, these interactions must be further
characterized to tease apart the relevant partners.
Interestingly, in yeast only Rhol and Cdc42 are
essential, Rho3 does exhibit growth defects upon
deletion, but does not meet the strict requirements to be
labeled as essential.

This raises the question about the

interaction of S406 with non-essential Rhos, since S406
must interact with an essential protein to cause
lethality.

The answer could be that S406 interacts with

multiple Rho proteins to cause lethality.
One way to accomplish characterization of these
interactions would be to use knockout mutations, however
an obstacle to this approach is the fact that Rhol and
Cdc42 are essential genes.

In order to work around the

problem of Rhol and Cdc42 being essential, there are
dosage rescue genes of these knockout mutations available

(Table 13). We would be able to co-transform knockout
yeast strains of Rhol and' Cdc42 with a plasmid
overexpressing one of the dosage rescue genes along with
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S406, both from the inducible GAL1 promoter.

These yeast

could then be analyzed by serial dilution replica plating
and titer assay, to determine if S406 is still lethal.
Our hypothesis in performing this experiment would be
that if yeast survive the effects of S406, then we have
identified an important interaction.
Table 13. Essential Rho genes and their dosage rescue
genes .
Dosage rescue genes Reference
Hirano et al. , 1996, Nonaka
bem4, slt2,
pkcl,
et al.,
1995, Helliwell et
rornl, rom2,
slgl,
al., 1998, Kamada et al.,
wsc3, mtll,
zdsl,
Rhol
1996, Ozaki et al., 1996,
msbl,
irel,
mid.2,
Sekiya-Kawasaki et al.,
irgl
2002, Rajavel et al., 1999
Kozminski et al., 2003,
Leberer et al.,
1996, Adamo
et al.,
2001, Gao et
al.,
rsrl,
beml,
bem4,
2007, Mack et al.,
1996.,
cdcl2,
cdc24,
Richman et al., 19 99,
ste20,
cla4,
kinl,
Barale et al., 2006, Ziman
msbl,
msb3,
sec4,
and Johnson 1994, Matsui
sec9,
axl2,
sro7,
and Toh, 1992, Dong et al. ,
Cdc42
sso2,
bem3,
rgal,
2003, Eby et al., 1998,
zdsl,
zds2,
px.ll,
Bender and Pringle 1989,
swhl,
osh2,
kesl,
Zhao et al.,
1995, Elbert
osh6,
osh3,
kin2,
et al.,
2005, Bender and
elml,
gin4
Pringle 1991, Bi et
al.,
2000, Kozminksi et
al.,
2006

The interaction of S406 with non-essential Rho2,
Rho3 and Rho5 also needs to be characterized.

Since

these Rhos are non-essential, it poses an interesting
question.

Is S406 interacting with more than one Rho to
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cause lethality?

For example, is it a combination of its

interaction with Rho2 and Rho5, Rho2 and Rho3, etc. that
causes lethality?

To answer this question we can use

knockout mutants.

We can create a double knockout mutant

of each combination.

We can transform this strain with

S406 to assay lethality.

Again, our assumption here

would be that if S406s interaction with Rho2 and Rho5
were the mechanism to cause lethality, knocking them out
would alleviate this lethal effect.
By performing these two assays we will be able to
determine which yeast Rhos are essential to cause S406
lethality.

We may find that although S406 is able to

interact with all of the yeast Rhos and Cdc42, that not
all of these interactions are essential for lethality.
This could especially be the case with the non-essential
Rhos 2, 3 and 5.
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APPENDIX A.
Actin Distribution is Disrupted upon Expression of
Yersinia
YopO/YpkA in Yeast.

ABSTRACT
Pathogenic Yersinia

spp. use a Type III secretion system

to inject effector proteins directly into host cells.
The effector proteins interfere with normal cellular
signaling and disrupt cytoskeletal structures that are
required for phagocytosis of the invader.
that Saccharomyces

cerevisiae

Here we show

responds to one of these

effector proteins, YopO/YpkA, essentially as has been
observed in mammalian model systems.

Expression of YopO

in yeast results in inhibition of growth on solid medium.
YopO expression confers a cytotoxic effect upon yeast
with only 6% of cells remaining viable after three hours
of expression.

Moreover, there is no obvious cell cycle

arrest associated with cytotoxicity.

YopO expression

disrupts the normal distribution of actin in yeast.
Actin is no longer observed exclusively at sites of cell
growth.

Concurrent with disruption of actin, we find

YopO localizes to the cell periphery where it may disrupt
actin localization. Inactivation of the YopO kinase has
no apparent effect upon the deleterious effects of YopO.
Collectively, our results show that the yeast model
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system that has been constructed meets all requirements
to serve as an excellent genetic model to exploit
examination of YopO and its intracellular targets.
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INTRODUCTION
Bacteria have evolved numerous strategies for
overcoming host cellular defenses that are elicited upon
infection (reviewed in [Celli and Finlay, 2002; Hornef,
et al., 2002]).

One defense used by many pathogenic

gram-negative bacteria use a Type III Secretion system
(TTS) to disable the host cells immune response and
continue to grow unimpeded within the host [Aepfelbacher,
et al., 1999; Cornells, 2002; Cornells and Wolf-Watz,
1997; Hueck, 1998].

In Yersinia

spp. this process

involves binding to the host cell, construction of a pore
through the host cellular membrane, injection of effector
proteins through the pore and finally, interaction of the
bacterial effector protein(s) with host proteins to
subvert the ability of the host cell to respond to the
infection.
Six effector proteins have been identified in
Yersinia.

YopE is a GTPase activating protein [Andor, et

al. , 2 001; Black and Bliska, 2 000; Von Pawel-Rammingen,
et al. , 2000] that disrupts the ability of Rho GTPases to
stimulate actin polymerization for internalization of the
bacterium

[Rosqvist, et al., 1991; Viboud and Bliska,

2001]. YopT is a cysteine protease that cleaves the
prenylated cysteine from RhoA, Rac and Cdc42 resulting in
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liberation of the GTPases from the cell membrane [Shao,
et al., 2003; Sorg, et al., 2001; Zumbihl, et al . , 1999].
YopH is a tyrosine phosphatase [Guan and Dixon, 1990]
that binds substrates in the focal adhesion complex using
an amino-terminal substrate recognition domain [Black, et
al., 1998; Montagna, et al., 2001]. The C-terminal
phosphatase domain dephosphorylates components of the
complex, thwarting phagocytosis of the bacterium
[Deleuil, et al., 2003; Hamid, et al. , 1999; Persson, et
al., 1999]. YopP/J is a cysteine protease that induces
apoptosis by blocking NF-kB and MAPK signaling pathways
in macrophages [Orth, 2002; Orth, et al., 1999; Orth, et
al., 2000; Ruckdeschel, et al., 2001].

YopM, a Leucine-

Rich Repeat protein, is required for virulence [Leung, et
al., 1990] and forms tetramers [Evdokimov, et al., 2001];
little else is known.
YopO/YpkA is a serine/threonine kinase [Galyov, et
al., 1993] that induces morphological changes [Hakansson,
et al., 1996] and disruption of the actin cytoskeleton
[Juris, et al., 2000] in cultured HeLa Cells. YopO is
initially produced as an inactive kinase until it
interacts with actin through the C-terminal 20 amino
acids [Juris, et al., 2000].

Surprisingly, the

serine/threonine kinase activity once activated is not
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required for disruption of the actin cytoskeleton [Juris,
et al., 2000] . YopO/YpkA also interacts directly with the
small GTPases, RhoA and Racl [Barz, et al., 2000;
Dukuzumuremyi, et al., 2 000], but the YopO kinase does.
not phosphorylate either protein.

It remains to be seen

if YopO is a multifunctional protein 'or whether RhoA,
Racl, actin and the YopO kinase all act in concert to
produce the disruption in the actin cytoskeleton.
Complete analysis of the Yop proteins and the
interaction with host protein targets has been hampered
by the lack of a genetically tractable host cell or model
system.

Lesser and Miller [Lesser and Miller, 2001]

began construction of a Yop model system in yeast by
showing that YopE and YpkA/YopO inhibit growth when
expressed from a high-copy plasmid.
Here we present evidence that expression of YopO
under the regulation of the inducible GAL1 promoter is
not only inhibitory but is cytotoxic to yeast. This
provides a conditionally lethal genetic system that can
be exploited to dissect YopO function in the cell.
Furthermore, loss of viability of the yeast strain is
concurrent with disruption of actin cytoskeletal
structures in a manner similar to phenotypes observed
upon Yersinia

infection of HeLa cells [Juris, et al. ,
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2000]. Our data suggest that Saccharomyces
an excellent model system to study Yersinia
its specific effect upon cellular targets.

cerevisiae

is

YopO/YpkA and
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RESULTS and DISCUSSION
Construction of YopO model system in yeast
Saccharomyces

cerevisiae

proteins and systems share

significant functional similarities to mammalian signal
transduction pathways, cell cycle regulatory pathways and
proteins involved in constructing and modifying the
cytoskeleton.

This led us to examine whether the well-

established yeast genetic system could be used to model
the interactions of Type III secretion system effector
proteins and their intracellular protein target(s). For
yeast to function as a useful genetic model system, we
will require the following conditions be met.

First,

expression of the effector protein must produce a
phenotype on solid medium that can be exploited using
genetics.

Second, expression of the effector protein

must be cytotoxic to yeast and not just cytostatic.
Third, mutant phenotypes must be consistent with
phenotypes established in other systems. Finally,
expression of the effector protein must disrupt/interact
with at least one yeast homologue of a cellular target
already described for the effector protein in other model
systems.
To test our genetic model, we created a yeast
plasmid, pLN5, which contains Yersinia

enterocolitica
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yopO under the control of the yeast galactose inducible
GAL1 promoter.

DNA encoding one copy of the V5 epitope

and six copies of the Histidine affinity purification tag
are fused at the 3' end of yopO.
pJG485, lacking yopO,

A control plasmid,

but retaining all other plasmid

sequences was constructed. Finally, two plasmids
expressing mutant alleles of yopO were constructed by
site-directed mutagenesis.

The first plasmid, pJG502,

contains a mutation at codon 267 that changes aspartic
acid 267 to alanine (D267A).

Aspartic acid 267 is the

same conserved residue in the kinase domain of YopO that
Dukuzumuremyi et al

constructed in YpkA and showed that

it was kinase deficient [Dukuzumuremyi, et al., 2000] .
The second plasmid, pJG505, contains a mutation at codon
543 that inserts a stop codon in amino acid 1543
resulting in truncation of the YopO protein (1543). This
removes the C-terminal actin and RhoA-binding domains of
YopO [Dukuzumuremyi, et al., 2 000; Juris, et al., 2 0 00] .
All four plasmid constructs were transformed into wild
type yeast strain JGY4 and selected on media lacking
uracil to isolate a strain containing each plasmid.
YopO is produced in yeast
Yeast strain JGY4 containing pLN5 was grown in
minimal selective media until mid-log phase.

Galactose
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was added to the culture to induce production of the
Yop0-V5 construct.

Aliquots of cells were taken at one-

hour intervals, whole-cell protein extracts were prepared
and the cell extracts were separated through a 9% SDS
polyacrylamide gel during electrophoresis.

The separated

proteins were transferred to PVDF membrane and probed
with an anti-V5 antibody.

As shown in Figure 1, a small

amount of YopO was evident even after one hour of
galactose induction.

During the course of the

experiment, YopO increased until it reached an observed
maximum level at three hours.
Expression of YopO is lethal to yeast
We examined whether expression of YopO disrupted
growth of yeast by comparing strains containing each of
the yopO plasmids with one containing a control plasmid
(figure'2).

All strains were replica plated onto Sgal-

ura medium and allowed to grow at 3 0°C for four days.

As

shown in figure 2, the strain containing the control
plasmid grew as expected and produced colonies at all
dilutions.

Conversely, the strain containing the YopO

plasmid did not grow on Sgal-ura plates.

This is in

agreement with a recent study by Lesser and Miller that
demonstrated that strains expressing YpkA were unable to
grow [Lesser and Miller, 2001].

The D267A strain also
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did not produce colonies on Sgal-ura plates in perfect
agreement with recent findings [Dukuzumuremyi, et al.,
2000; Juris, et al., 2000]. Furthermore, the 1543 strain
(lacking actin and RhoA binding region) was not lethal to
yeast in perfect agreement with findings of Juris et al
[Juris, et al., 2000] and Dukuzumuremyi et

al

[Dukuzumuremyi, et al., 2000] which showed that the Cterminal region was essential for disruption of actin
localization by YpkA in mammalian cells.
Comparison of the growth of successive 40-fold
dilutions of the control and YopO strain demonstrates
that the strain expressing YopO is at least four orders
of magnitude less able to grow than a strain containing a
control plasmid.

Both strains grew as expected on SD-ura

medium which does not induce yopO.

Likewise, both

strains grew at a similar rate in SD-ura liquid medium
with a doubling occurring once every-1.6 hours (data not
shown).

Thus, yeast must contain a protein(s) that

serves as a cellular target(s) of YopO when YopO is
conditionally expressed in the yeast.

Furthermore, YopO

requires the same domains for disruption of growth in

yeast as that seen in mammalian cells. This finding
fulfills our first requirement for yeast to serve as a
model genetic system for investigation of Type III
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secretion system effectors; expression of YopO results in
inhibition of growth on solid medium.
Inability to grow on solid media containing
galactose could be due to loss of viability or a result
of arrested growth of the cells.

To determine which of

these possibilities were correct, we inoculated the
control and YopO expressing strains into liquid medium
supplemented with raffinose as the sole carbon source.
Growth in raffinose medium prepares the cells for a quick
shift to galactose as compared to glucose by priming the
galactose utilization mechanism [Guthrie and Fink, 1991].
Thus, a faster induction of yopO can be achieved upon
addition of galactose to the medium.
To determine if expression of YopO and D267A is
cytostatic or cytotoxic, we measured all strains to
determine the number of cells able to grow on solid
dextrose medium after removal from galactose induction
(figure 3 ) . The yeast strain containing the control
plasmid increased throughout the course of the eight-hour
experiment at a rate of one doubling of colony forming
units every 4.2 hours.

This rate is in close agreement

with the rate (3.4 hours) observed when the actual number
of cells is counted for the same strain (data not shown).
The small difference in rate is likely due to the fact
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that in the viability experiment, we require the cells to
grow on SD-ura and only those cells maintaining the
plasmid will be able to grow.

In the cell count, we are

counting cells whether they contain plasmids or not.
Conversely, the number of viable cells in the culture of
the strain expressing YopO decreased 1 hour after
addition of galactose (figure 3 ) . By the third hour,
when the maximum amount of YopO was observed by western
analysis, only 2.5% of the cells in the YopO expressing
strain remained viable.

Likewise, the strain containing

the mutation in the kinase domain (D267A) also decreased
at a rate similar to YopO with 4.2% remaining after 3
hours.

Thus expression of YopO and D267A is cytotoxic to

yeast.

Unexpectedly, we observed that the 1543 strain

did not increase in number of viable cells nor did it
decrease like YopO and D267A.

After six hours, 91% of

the original number of viable cells still remained (data
not shown).

The growth rate and cell number of the 1543

strain was examined and no noticeable difference from the
control was observed (data not shown).

Thus 1543, which

lacks the defined RhoA and actin-binding site

[Dukuzumuremyi, et al., 2000; Juris, et al., 2000], must
still retain some function (kinase and/or another Nterminal site) that allows it to interact with cellular
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components resulting in the decreased viability of the
cells during growth and division.
We further examined the effect YopO expression had
upon yeast by examining whether the loss of viability due
to expression of YopO. had its effect at a specific time
during the cell cycle or whether it was a more general
loss of viability.

In yeast, cell cycle progression can

be estimated by monitoring the size of the new bud being
produced from the mother cell.

All four strains were

examined at one hour and three hours after addition of 2%
galactose. All four strains had no significant change in
distribution of cells in the unbudded, small, medium or
large bud categories at the zero time point and after
three hours (data not shown).

This suggests that the

lethality imposed by expression of YopO (and D267A) does
not arrest the cell at a specific time in the cell cycle,
but kills the cell regardless of the position within the
life cycle of the cell.

To confirm that this is true, we

arrested the control and YopO strain in the Gl phase of
the cell cycle with a-factor [Guthrie and Fink, 1991].
The cells were released from a-factor arrest and YopO was
induced with galactose after one hour of growth.

After

three hours of growth in the presence of galactose, there
was no significant difference between the distributions
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of buds in each culture (data not show).

Furthermore, at

least 50% of the YopO cells exited Gl and grew new buds
before ceasing growth.

Under the same conditions, 4 0% of

the control cells grew new buds (data not shown).
Therefore the loss of viability of the YopO culture is
not directly due to disruption of cell cycle progression
nor is there an obvious cytostatic effect. These findings
fulfill our second requirement for yeast to serve as a
model genetic system for investigation of Type III
secretion system effectors; expression of YopO is not
cytostatic, but is cytotoxic to the cell.
Localization of Actin
YopO/YpkA has been shown to disrupt the actin
cytoskeleton in epithelial cells [Juris, et al . , 2000] .
We stained the control yeast strain and the strains
expressing ^YopO, D267A and 1543 with Rhodamine-phalloidin
to visualize actin.

Cells were examined at one-hour time

points following addition of galactose.

Representative

cells from each time point are shown in figure 4.

Actin

localization in yeast is primarily at sites of cell
growth

1984].

[Novick and Botstein, 1985; Shortle, et al.,

As seen in the control strain there are two types

of actin; cytoplasmic cables and cortical patches
[Mulholland, et al., 1994]. Both forms of actin are
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identifiable in all time points of the control strain
following addition of galactose.

Both forms of actin are

also observed at zero and one hour post galactose
induction in the YopO, D267A and 1543 strains.

On the

contrary, at the third hour after galactose induction,
the actin in the YopO and D267A strain has become more
diffuse and cables are not observed.

This phenotype

exists through out the six hours the cells were observed.
Cortical patches become less intense, localization of the
majority of actin to the growing bud tip decreases and
cables are no longer evident.

The disruption of yeast

actin is coincident with the fall in viability after two
hours of induction of YopO and D2 67A. Thus YopO disrupts
actin localization in yeast like YopO expression in
mammalian cell models [Barz, et al., 2000; Dukuzumuremyi,
et al., 2000; Juris, et al., 2000]. These findings
fulfill our third and final requirement for yeast to
serve as a model genetic system for investigation of Type
III secretion system effectors; YopO disrupts the normal
distribution of actin in a yeast cell.
The 1543 strain results are mixed.

Actin cables are

still evident through the six hours of the experiment,
but localization of actin to the growing bud is less
acute.

Similar to the results shown in figure 3, this
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suggests that the 1543 mutant, which is missing the Cterminal actin and RhoA binding sites, still has a
function that is evident when expressed in yeast.

Quite

possibly this function is also involved in disruption of
actin distribution in the cell.
Localization of YopO
We next examined the cellular localization of YopO
and D267A (figure 5 ) . Strains expressing the control,
YopO and D2 67A plasmids were induced with galactose and
prepared for indirect immunofluorescence.

After three

hours of expression (maximum expression by western), we
observed that YopO localized throughout the whole cell,
but seemed to be concentrated at discrete spots at the
cell periphery.

No additional difference was seen as we

extended the induction of the YopO strain to six hours.
This localization is very similar as to that seen by
Hakansson et al in HeLa cells [Hakansson, et al., 1996] .
Furthermore, D267A localized within the cell in a manner
similar to YopO.

This suggests that a functional kinase

domain is not necessary for localization within the cell
as seen in higher eukaryotes and that the lethality

induced by YopO may require localization to the plasma
membrane where it likely interacts and disrupts actin.
Cellular Targets
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What are the cellular targets of YopO/YpkA in yeast?
Juris et al [Juris, et al., 2000] have demonstrated that
actin physically interacts with the C-terminus of YpkA
and is required for activation of the kinase activity.
Despite this, the authors go on to show that the kinase
activity is not necessary for actin disruption since a
mutation in YpkA that disrupts the kinase activity is
still able to disrupt actin structures in epithelial
cells, presumably through binding directly to actin via
the C-terminus.

Two groups [Barz, et al., 2 000;

Dukuzumuremyi, et al., 2000] have established that
YopO/YpkA is a RhoA/Racl-binding protein, but neither
GTP-binding proteins are required for kinase activity.
YpkA directly interacts with RhoA, but does not affect
the GDP/GTP exchange reaction [Dukuzumuremyi, et al.,
2000] suggesting a novel use of the GTP-binding factors
upon bacterial infection.

How these targets and

activities work together at the molecular level to
disrupt actin structures upon infection by
remains to be seen.

Yersinia

With the YopO/yeast model system

functioning in a manner similar to that observed in

mammalian models, we can now bring the power of the yeast
genetic system to bear on these important questions.

104
ACKNOWLEDGEMENTS
We thank Olaf Schneewind for his gift of the
Yersinia

enterocolitica

virulence plasmid.

We are

indebted to Bruce Bejcek and Silvia Rossbach for
discussions and critical readings of this manuscript.

EXPERIMENTAL PROCEDURES

Media
LB medium has been previously described [Sambrook, et
al . , 1989] . Yeast media YPD, S-ura, SD-ura and Sgal-ura
have been previously described [Guthrie and Fink, 1991].
Plasmid construction
Plasmids used in this study are listed in Table 1.
Plasmid p416 GAL1 [Mumberg, et al., 1994] contains a
URA3 marker for selection and a galactose inducible GAL1
promoter.

Plasmid p416 GAL1 was digested with S a d and

Smal and blunted with T4 DNA Polymerase.

The GATEWAY™

insert of pYES-Dest52 (Invitrogen) was liberated by
digesting the vector with Pmel and Spel followed by
blunting with T4 DNA Polymerase.

The p416 GAL1 vector

and GATEWAY™ insert were ligated together using T4 DNA
Ligase to create plasmid pJG485.
YopO was PCR amplified from plasmid pYV227 (gift of
Olaf Schneewind) using N-terminal oligonucleotide attBlYopO (5'GGGGACAAGTTTGTACAAAAAAGCAGGCTCAATGAAAATCATGGGAACTATG- 3' ,
ATG is underlined) and C-terminal oligonucleotide attB2YopO (5'GGGGACCACTTTGTACAAGAAAGCTGGGTCTCACATCCATTCCCGCTC-3',
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inverse of TGA is underlined).

Amplified PCR fragments

were mixed with pDONR201 and allowed to recombine using
the GATEWAY™ BP reaction (Invitrogen) .

The resulting

plasmid, pLN3, contains YopO with attLl and attL2
flanking sequences.

YopO sequences contained in pLN3,

and attLl and attL2 flanking sequences were completely
sequenced to assure that amplification proceeded as
expected.

Only one mutation was found, Q438R.

The QuikChange XL Site-Directed Mutagenesis Kit
(Stratagene) was used to change sequences within pLN3.
Oligonucleotide YopO-4 (5'GCTCGTCAGTCCCTGCAGCGTTTTGACAGTACCCG-3') and complementary
oligonucleotide YopO-4rev

(5'-

CGGGTACTGTCAAAACGCTGCAGGGACTGACGAGC-3') removes the Q438R
mutation and returns it to wild type. Oligonucleotide
YopO-5 (5'- GAGCGGGAATGGATGGCAGACCCAGCTTTCTTGTAC-3') and
complementary oligonucleotide YopO-5rev (5'GTACAAGAAAGCTGGGTCTGCCATCCATTCCCGCTC-3') removes the stop
codon.
The GATEWAY™ LR reaction (Invitrogen) was used to
create pLN5 through recombination of plasmids pLN3 and
pJG485.

This results in a yeast plasmid that will

express the YopO-V5-6xHis construct upon addition of
galactose to the media.

The QuikChange XL Site-Directed Mutagenesis Kit
(Stratagene) was used to mutate codon 267 in plasmid pLN5
to create the D267A mutant.

Oligonucleotide D267A (5'-

CAGGGATAGTACATAACGCTATCAAACCCGGTAATGT-3' ) and
complementary oligonucleotide D267A-rev (5'ACATTACCGGGTTTGATAGCGTTATGTACTATCCCTG-3') were used to
change the Aspartic Acid residue to Alanine.

Likewise,

oligonucleotide YopO-7 (5'GAACCTTCACTGCAGAGGTAGCAAAAGCATCTGGACCAG-3') and
complementary oligonucleotide Yop0-7rev (5'CTGGTCCAGATGCTTTTGCTACCTCTGCAGTGAAGGTTC-3') were used to
insert a stop codon at residue 543.

This creates a

vector that express a truncation of YopO that includes
residues 1 - 54 2.
Yeast
Transformation of each yeast strain was performed
essentially as described [Gietz and Schiestl, 1991] .
Yop0-V5 containing strains were grown in S-ura medium
containing 2% raffinose. Strains were maintained in log •
phase for at least three doublings before galactose was
added and YopO expression was induced.

Induction of YopO

was accomplished by adding 2% galactose directly to the S
raffinose medium when the cells reached mid-log phase
(-60 Klett).
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Yeast Extracts
Yeast cultures were grown in S-ura minimal medium
containing 2% raffinose until mid-log phase (-60 Klett).
Galactose was added to 2% final concentration at time
zero.

10 ml aliquots of un-induced and induced cultures

were taken at every hour for four hours.

Extracts were

prepared from each aliquot as previously described
[Kahana, et al . , 1998] .

150 jig of extract from each time

point was separated on a 9% SDS polyacrylamide gel
[Laemmli, 1970] and transferred to PVDF membrane
overnight at 30 Volts [Sambrook, et al., 1989].
Western immunoblotting was accomplished by blocking
with .2% I-block (Tropix) in PBS followed by adding the
anti-V5 antibody (Invitrogen) at 1:2000 dilution and
incubating overnight at 4°C.

The YopO-V5 protein was

visualized using the ECL Western Blotting Analysis Kit
(Amersham).
Actin Localization
Cells were fixed in 3.7% formaldehyde for two hours
at room temperature.

Cells were concentrated 20-fold,

suspended in PBS-BSA (.04%) supplemented with Rhodaminephalloidin (Molecular Probes) at a final concentration of
66 units/ml and incubated in the dark for 30 minutes at
room temperature.

Cells were washed three times with
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PBS-BSA (.04%) and suspended in 30 pil of PBS-BSA (.04%).
Visualization of actin was performed using a Nikon
Microphot FXA and CCD camera using a Texas Red filter
set.
YopO Immunofluorescence
Immunofluorescence was performed essentially as
described [Geiser, et al., 1997].

Briefly, aliquots of

cells were taken at each time point and fixed in 3.7%
formaldehyde at room temperature for two hours.

The cell

wall was digested with 50 /xg/ml (final concentration)
Zymolyase 100T (US Biological) dissolved in 1.2 M
Sorbitol, 25mM •-mercaptoethanol, and lOOmM KP04 pH 7.5
for one hour at 30°C.

Cells were washed in PBS-BSA

(.04%) and attached to polylysine coated slides.

To

visualize YopO, mouse monoclonal anti-V5 antibody
(Invitrogen) was diluted 1:800 with PBS-BSA (.04%) and
applied for two hours at room temperature. Following wash
with PBS-BSA (.04%), goat anti-mouse CY2 (1:100) was
applied for 2 hours at room temperature.

DNA was stained

with DAPI (4',6-Diamidino-2-phenylindole dihydrochloride,
Sigma-Aldrich) for 3 minutes at room temperature.
Visualization of YopO was performed using a Nikon
Microphot FXA and CCD camera using a FITC filter set.
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TABLE 1 - Plasmids used in this study.
Plasmid

Description

p416 GAL1

CEN6 ARSH4

pDONR 201

KmR

pJG485

C E N 6 A R S H 4 U R A 3 PQALI-(attRl C m R ccdB attR2)-V5-

(attPl

Reference
URA3

PQALI-

CmR c c d A

[Mumberg,
etal, 1994]
Invitrogen

CYC 1 term
ccdB

attP2)

This study

6xHis-CYClterm

pLN3

KmR

pLN5

CEN6 ARSH4 URA3 P G A L 1 -YopO-V5-6xHis-

pJG502
pJG505
pYES-Dest52

(attLl-YopO-attL2)

C " C I term
CEN6 ARSH4 URA3
6xHiS-CYClterm
CEN6 ARSH4 URA3
C i L-J-term

This study
This study

PGAL1-YopO (D267A) -V5 -

This study

PGAL1-YopO ( 1 5 4 3 )

This study

-V5-6xHis-

2 p. URA3 PGALi - (attRl CmR ccdB attR2)-V5 - 6xHi s -

Invitrogen

ClClterm

TABLE 2 - Yeast strains used in this study.
Strain
JGY4

Description
MATalys2-801 his3-A200 leu2-3,112 ura3-52

Reference
M. Andrew
Hoyt

0

1

2

3

4

hr

220 k D 97 kD

66 kD -

_ . .

YopO

45 kD

30 k D - .
FIGURE 1 - YopO is produced in yeast.

Yeast strain JGY4

pLN5 was induced with galactose for four hours.

Aliquots

of the strain were taken at 1 hour intervals and extracts
prepared.

The level of Yop0-V5 in un-induced and induced

cultures was determined by immunoblotting.
weight markers are shown.

Molecular

Control
YopO
D267A
1543
Control
YopO
D267A

SG

1543
FIGURE 2 - YopO is lethal in yeast.

Yeast strain JGY4

containing control (pJG485), YopO (pLN5), D267A (pJG502)
and 1543 (pJG505) plasmids were replica plated to SD (SDura) or SG (Sgal-ura) medium and incubated at 3 0°C for
four days.

Each spot of cells is a 40-fold dilution of

the cells in the previous spot. The translucent region in

the most concentrated YopO and D2 67A spot on SG is a
result of cells that were originally plated and is not
actual growth.

FIGURE 3 - Examination of cell viability of yeast
containing YopO. Strain JGY4 containing YopO (pLN5),
D267A (pJG502), 1543 (pJG505) or a control plasmid
(pJG485) was grown in selective medium containing 2%
raffinose.

Galactose (2%) was added to the medium at the

zero time point to induce YopO.

At each time point, 1 ml

aliquots were sonicated to separate cells that had
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undergone cytokinesis followed by serial dilution onto
SD-ura plates (lacks galactose). Each curve shown is
representative of three different trials for each strain.
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Control

YopO

D267A

1543

Ohr

lhr

.•V* I lb Jr

3 hr

6 hr
FIGURE 4 - Localization of actin in yeast expressing
YopO. Strain JGY4 containing YopO (pLN5), D267A (pJG502),
1543 (pJG505) or control plasmid (pJG485) was grown in
selective medium containing 2% raffinose.

Galactose (2%)

was added to the medium at the zero time point to induce
YopO.

Aliquots were taken at each time point and fixed

with 3.7% formaldehyde for two hours.

Rhodamine-

phalloidin was added to visualize actin (see methods).
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Control

YopO

D267A

Ohr

3hr

6 hr

FIGURE 5 - Localization of YopO in yeast. Strain JGY4
containing YopO (pLN5), D267A (pJG502), or a control
plasmid (pJG485) was grown in selective medium containing
2% raffinose.

Galactose (2%) was added to the medium at

the zero time point to induce YopO. Aliquots were taken
at each time point and fixed with 3.7% formaldehyde for
two hours.

Immunofluorescence was used to visualize the

V5 epitope at the C-terminal end of YopO.
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